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Abstract

CHARACTERIZATION OF THE REGULATION AND FUNCTION OF NEISSERIA
GONORRHOEAE TONB-DEPENDENT TRANSPORTERS: TDFG, TDFH AND TDFJ

By Sophonie Jean, B.S.

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2015

Major Director: Cynthia Nau Cornelissen, Ph.D.
Professor, Department of Microbiology and Immunology

The obligate human pathogen Neisseria gonorrhoeae successfully overcomes
host strategies to limit essential nutrients, termed “nutritional immunity” by expression of
TonB-dependent transporters (TdTs): outer membrane receptors that facilitate nutrient
transport in an energy-dependent manner. N. gonorrhoeae encodes eight TdTs, five of
which facilitate utilization of iron or iron-chelates from host derived proteins including
transferrin, lactoferrin and hemoglobin, in addition to siderophores from neighboring
bacteria. The transferrin utilization system was previously shown to be critical for
establishing infection in human males; demonstrating the possible contributions of TdTs

xvi

to gonococcal pathogenesis. As such, studies describing the biological function and
contribution to pathogenesis of the remaining three uncharacterized TdTs (TdfG, TdfH
and TdfJ) are needed. In this study we report that neither TdfG, TdfH nor TdfJ are heme
receptors as gonococcal heme utilization occurs passively, independent of energy
derived from the TonB system. We also report that TdfH and TdfJ are zinc (Zn)
regulated and identify virulence associated regulators that modulate expression of these
TdTs, which is in some cases strain-specific. We report that both TdfH and TdfJ
contribute to Zn acquisition in N. gonorrhoeae and we characterize TdfH as a
calprotectin receptor. Calprotectin, an immune effector protein highly expressed in
neutrophils, has antimicrobial activity due to its ability to sequester Zn and Mn. We
present evidence that TdfH confers resistance to calprotectin and that TdfH facilitates
gonococcal calprotectin binding and Zn accumulation in the presence or absence of
calprotectin. Finally, we demonstrate that TdfH expression enhances N. gonorrhoeae
NET survival. These studies identify for the first time a novel gonococcal defense
strategy to host-mediated nutritional immunity, in which N. gonorrhoeae, via the TdT
TdfH, utilizes calprotectin as a Zn source neutralizing its antimicrobial activity. These
studies have yielded novel insights into the function and regulation of TdfG, TdfH and
TdfJ in N. gonorrhoeae and have laid the framework for future investigation of TdTmediated Zn acquisition and its role in bacterial pathogenesis.

xvii

Chapter 1: Introduction

I. Neisseria
The genus Neisseria belongs to the family Neisseriaceae, which is also
comprised of 3 other genera: Moraxella, Acinetobacter and Kingella [121]. Members of
the Neisseriaceae family can be differentiated from one another by cell morphology and
biochemical properties such as the ability to produce acid from glucose and reduce
nitrate as well as the presence of oxidase, catalase, carbonic anhydrase and thymidine
kinase [25]. The Neisseria genus is comprised of a number of species which can occur
as normal flora or pathogens in humans. The Neisseria species are non-motile, Gramnegative diplococci with flattened adjacent sides that are aerobic or facultatively
anaerobic and grow optimally at temperatures between 35-37°C [25]. Human
associated Neisseria spp. can be identified by their acid production from carbohydrates,
their ability to reduce nitrite and produce polysaccharide from sucrose [121].

II. Pathogenic Neisseria species
The only Neisseria species that is always considered pathogenic is Neisseria
gonorrhoeae. It infects the mucosal surfaces of urogenital sites and the oronasopharynx, causing symptomatic or asymptomatic infections. In some cases,
1

Neisseria meningitidis can be pathogenic causing sporadic cases or epidemics of
meningitis. Strains of N. meningitidis can be carried as normal flora in the nasopharynx
of healthy individuals. Most Neisseria species are commensal and colonize the
oropharynx without causing disease. Some commensal species have been sporadically
isolated from disseminated sites, blood, and cerebrospinal fluid, although they are not
normally associated with invasive infections. Commensal species appear to be
opportunistic pathogens, causing infection in people with deficient immune systems
[121].

III. Meningococcal disease
A. Epidemiology
Neisseria meningitidis colonizes the nasopharynx where it exists as a
commensal bacterium. Though carriage rates can vary among human populations, as
many as 10% of adolescents and adults are asymptomatic carriers [37].Transmission of
N. meningitidis can occur directly via person-to-person contact or through respiratory
droplets from an infected to a susceptible individual. As such, transmission and carriage
rates increase dramatically in closed settings such as residential schools and military
camps [37]. Carriage can last as long as months and is least prevalent in the early
years of life and most prevalent in young adults [218]. Persons with immune
deficiencies such as deficiencies in terminal complement components have increased
susceptibility to meningococcal disease as well as people with exposure to tobacco
smoke and concurrent viral infection of the upper respiratory tract [199].

2

Despite high carriage rates, meningococcal disease is rare, occurring at annual
incidence rates of 1-1000 per 100,000 population throughout the world [37]. N.
meningitidis strains can be separated into thirteen different serogroups on the basis of
the polysaccharide capsule, of which six (A, B, C, W135, X and Y) are responsible for
the majority of invasive meningococcal disease [218]. The highest incidence of
meningococcal disease occurs in sub-Saharan Africa in the ‘meningitis belt’ where
incidence can approach up to 1000 cases per 100,000 population during epidemics
[89]. Serogroup A is most important in this region, though Serogroups C and X can also
cause disease [89]. In the Americas, Serogroups B, C, and Y are predominant
meningococcal disease causing strains and result in historically low incidence of
diseases at 0.3-4 cases per 100,000. Serogroups B and C predominate in Europe,
Australia, and New Zealand where incidence varies between countries from 0.2-14
cases per 100,000. In Asia, the burden of meningococcal disease is less well defined,
though serogroups A and C are thought to be responsible for the infrequent outbreaks
and low levels of endemic disease in the region [89].
B. Infection
In less than 1% of colonized individuals, meningococci penetrate the mucosal
epithelia and enter the bloodstream to cause meningococcemia [41]. In half of the cases
of meningococcal septicemia, the bacteria penetrate the blood brain barrier causing
meningitis, the most common presentation of invasive meningococcal disease, which
presents clinically as sudden onset of headache, fever, and neck stiffness and is
sometimes accompanied by nausea, vomiting, sensitivity to light and altered mental
status [199]. Meningococcemia or bloodstream infection is characterized by sudden
3

fever and rash and is often associated with hypotension and multi-organ failure [199].
The overall case fatality rate of invasive meningococcal disease is 9 -12%, with a rate of
up to 40% among patients with meningococcal sepsis [199]. A significant number of
meningococcal survivors have sequelae such as hearing loss, neurologic disability, or
loss of a limb [199].
C. Treatment
N. meningitidis remains susceptible to many antibiotics including penicillin [199].
In the US, where few penicillin resistant strains have been reported, penicillin remains
the first line of therapy recommended after N. meningitidis infections has been
confirmed [41]. To prevent secondary infection of individuals with close contact to
patients with meningococcal disease, prophylactic treatment of household members is
often used as a method of control [199].
Several meningococcal vaccines are licensed for use in the US. MPSV4, the first
meningococcal polysaccharide vaccine was approved in 1974. The current
polysaccharide vaccine (Menomune; Sanofi Pasteur) confers protection against
Serogroups A, C, Y and W-135 [32]. However, it is poorly immunogenic in infants,
doesn’t confer long lasting immunity and does not reduce nasopharyngeal carriage of N.
meningitidis to elicit herd immunity [153]. As such it is only recommended in individuals
older than 55 years of age when other conjugate vaccines are not available [41]. Three
meningococcal conjugate vaccines are licensed in the US: two single component
vaccines—Menactra also known as MCV4 (Sanofi Pasteur) and Menevo (Novartis) and
a two-component vaccine MenHibrix (GlaxoSmithKline). MCV4 was approved in 2005
and has meningococcal A, C, W and Y polysaccharides conjugated to diphtheria toxoid
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protein carrier and is approved for use in persons from 9 months to 55 years of age
[153]. Menevo, licensed for use in 2010 in persons 2-55 years of age, contains the
meningococcal A, C, W and Y polysaccharides conjugated to CRM197 (MenA).
MenHibrix, was licensed for use in 2012 and contains N. meningitidis serogroups C
capsular polysaccharide conjugated to tetanus toxoid, N. meningitidis serogroup Y
capsular polysaccharide conjugated to tetanus toxoid and Haemophilus influenzae
serogroup B capsular polysaccharide conjugated to tetanus toxoid. It is recommended
as a 4 dose series in children between 2-18 months of age [41].
Until recently, there was no N. meningitidis serogroup B vaccine licensed for use
in the US, which causes 50% of invasive disease worldwide and 30% in the US [32].
Vaccine development strategies were hindered due to the fact that the polysaccharide
of N. meningitidis serogroup B contains polysialic structures identical to those
expressed in fetal neural tissue, and does not induce a protective IgG response [217].
As such, novel vaccine development strategies have focused on non-capsular antigens
[32, 199, 218]. Bexsero® also known as 4CMenB (Novartis), licensed for use in Europe
and Australia in 2013 and in the US in 2015, is the first broad-spectrum vaccine for N.
meningitidis serogroup B [130]. 4CMenB is comprised of 4 components against
meningococcal serogroup B: factor H binding protein (fHbp) fused to accessory protein
GNA 2091, Neisseria heparin binding antigen (NHba) fused to GNA 1030 and Neisseria
adhesin A (NadA) all added to an outer membrane vesicle from the serogroup B New
Zealand strain (strain NZ98/254) [130]. A second group B vaccine, Trumemba® (Pfizer),
which is composed of two fHbp variants (A05 and B01), was licensed for use in 2014
[130]. Despite the leaps on the development of vaccine strategies, comprehensive post-
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implementation surveillance plans will be required to monitor the inevitable loss of
immunity and the potential harmful effects of vaccination.

IV. Gonococcal disease
A. Epidemiology
Neisseria gonorrhoeae is the etiological agent of the sexually transmitted
infection, gonorrhea. Gonorrhea is a significant global health concern causing an
estimated 106 million new cases each year [267]. In the US, gonorrhea is the second
most commonly reported communicable disease with 820,000 estimated new cases
each year, less than half of which are detected and/or reported to the CDC. The key risk
factor for infection is new or multiple sex partners. In the US, incidence rates are
generally highest among adolescents and young adults, women and African Americans,
for whom the rate of reported cases was 12.4 times greater than that of whites [40]. For
the first time since 2003 the number of reported cases in men was greater than in
women in 2013 [40].
B. Infection
Neisseria gonorrhoeae is transmitted via close sexual contact of infected
individuals. It can be transmitted perinatally from mother to child during child birth. Thus,
newborn infants are treated with an ocular prophylactic agent (erythromycin) to prevent
gonococcal opthalmia [266]. Neisseria gonorrhoeae causes infection in the urogenital,
anorectal or pharyngeal mucosa. In men, infection is asymptomatic in a minority of
cases. When present, symptoms occur within 14 days of infection and present as
dysuria and purulent urethral discharge. Most women are asymptomatic. Symptoms
6

such as dysuria, increased vaginal discharge and vaginal bleeding can sometimes
present but are non-specific and often mistaken for a bladder or vaginal infection [159].
Rectal infection in both men and women can present as soreness, itchiness, discharge
and bleeding but can also be asymptomatic [120]. Most pharyngeal infection is
asymptomatic but can also cause sore throat [264].
Untreated infection can lead to complications and severe morbidity is associated
with downstream sequelae. In women, gonococcal infection can ascend to the upper
reproductive tract to cause Pelvic Inflammatory Disease (PID), which can increase the
risk of ectopic pregnancy and infertility. In men, complicated infection can lead to
epidymitis, which can rarely lead to infertility. Though rare, N. gonorrhoeae can also
enter the blood and cause Disseminated Gonococcal Infection (DGI), characterized by
arthritis, tenosynovitis and dermatitis [99, 196].Gonococcal infection is often associated
with other infections including Chlamydia trachomatis and can increase the risk of
acquiring other STI infection and the transmission of HIV [108].
C. Treatment
Antimicrobials have been successfully used to treat gonococcal infection for the
last 70-80 years [242]. However, the ability to treat gonococcal infection has become
increasingly difficult due to the development of antibiotic resistance. In the 1990-2000
decade, fluoroquinolone resistance spread throughout the US. As such, in 2007 the
CDC no longer recommended fluoroquinolones for treatment of uncomplicated
gonorrhea leaving 3rd generation cephalosporins as the last line of defense to treat
gonococcal infection [38]. In 2010 the STD Treatment Guidelines recommended dual
therapy with a cephalosporin—Cefixime (oral) or Ceftriaxone (intramuscular) plus
7

azithromycin or doxycycline for the treatment of co-occurring pathogen Chlamydia
trachomatis. However, treatment failures with cefixime and ceftriaxone and declining
cefixime susceptibility to collected urethral isolates reported by the CDCs Gonococcal
Surveillance Isolate Project (GISP) led to a 2012 revision, which now only recommends
ceftriaxone plus azithromycin or doxycycline as the only reliable treatment of
uncomplicated urogenital, anorectal, and pharyngeal gonorrhea [39].
Though the current recommendations appear to be effective, decreasing global
susceptibility to ceftriaxone and the prevalence of azithromycin resistance in many
settings as well as the prohibitive cost of dual-therapy in many resource poor settings
indicate that dual therapy regimens are more likely short-term solutions. Additionally,
multidrug resistant and extensively drug resistant strains have been reported throughout
the world [242], further validating fears of untreatable gonorrhea. Importantly,
gonococcal infection elicits no protective immunity and there is no vaccine for
preventative measures [277]. Thus, strategies to treat and combat the spread of
antimicrobial resistant gonorrhea are a top national and international priority.

V. N. gonorrhoeae virulence factors
N. gonorrhoeae expresses an array of surface molecules that help mediate its
interaction with the human host and successfully cause infection. These structures
contribute to adherence and invasion of mucosal sites as well as immune evasion and
so are briefly discussed below.
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A. Type IV Pilus
Type IV pili are filamentous polymers six nanometers in diameter and several
micrometers in length that extrude from the cell surface [162].Several genes are
involved in the biogenesis, assembly and disassembly of pili. The pilus fiber is mainly
comprised of individual subunits of the major pilin protein, PilE, arranged in a helical
configuration. Minor pilin proteins such PilC, PilV and PilX are also incorporated into the
pilus structure and modulate function [250]. PilD a peptidase/transmethylase, processes
the prepilin precursor and facilitates the incorporation of pilin subunits into the growing
fiber. PilQ forms an outer membrane secretin through which the fiber is extruded and
PilF and PilT contribute to fiber assembly and disassembly, respectively [265]. Pili have
multiple roles in gonococcal pathogenesis inducing bacterial self-agglutination [231],
attachment to eukaryotic cells [162] and twitching motility [163]. Type IV pili also
facilitate DNA uptake transformation and thereby contribute to the genetic variation [75].
Type IV pili undergo both phase and antigenic variation. Phase variation occurs
as a result of slipped strand mis-pairing event that occurs at the polyC-tract within the
pilE structural gene during DNA replication. The variable length of the polyC region
results in frame-shift mutation and reversible on/off variation [13, 123]. Antigenic
variation occurs as a result of high frequency gene conversion between the PilE
expression locus and one or more antigenically distinct pil genes in silent pil loci (pilS).
This process is RecA-dependent and uni-directional [95, 123].The pilus fiber can also
undergo post-translation modification such as glycosylation [220] as well as
phosphoethanolamine (PEA) and phosphocholine modification, which can modulate its
function [250]. Phase and antigenic variation and post-translational modification of pilus
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fibers are thought to inhibit host immune recognition. Antigenic variation of pili is thought
to be the biggest reason for the failure of a pili based vaccine to elicit protection [24,
250].
B. Porin
Neisserial porins are the most abundant outer membrane protein in Neisseria.
Like other members of the Gram-negative porin superfamily, neisserial porins are
comprised of three polypeptide subunits that form β-barrels and trimerize to form the
native porin structure, which facilitates the passage of small nutrients and waste
products across the outer membrane. Neisseria porins are anion selective and voltagegated [272]. N. meningitidis expresses two porins: class I (PorA), which is phase
variable [245] and either class 2 or class 3 (PorB). The limited antigenic variability of
porins form the basis of the neisserial serotyping system [74]. In N. gonorrhoeae, PorA
exists as a pseudogene due to mutations within the promoter and coding regions [69].
Thus, the gonococcus only expresses 1 porin that is homologous to the meningococcal
PorB. PorB is further classified as protein IA (PorB1A) or protein IB (PorB1B) [81].
In addition to their essential role in cell viability, porins also have roles in
gonococcal pathogenesis. Porins can spontaneously transfer as a functioning channel
into model membranes [151, 158] and eukaryotic cell membranes where the resulting
transient changes in voltage interfere with cell signaling [84, 114, 202]. Neisserial porins
have also been shown to interact with mitochondria, where it is thought to induce
calcium influx and apoptosis [167-168]; however, the role of porins in apoptosis is
controversial since some studies indicate that porin interaction with mitochondria
protects from apoptosis [156-157].
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Additionally, neisserial porins have been described to have immuno-modulatory
functions. Neisserial porins alter neutrophil signaling and inhibit neutrophil degranulation
and phagocytosis [21, 84]. Neisserial porins also contribute to B-cell activation through
induction of proliferation and enhancement of antibody secretion [213, 262]. As such,
PorB has been incorporated into vaccine formulations as an adjuvant [260].
Porins have also been described to have a role in invasion of epithelial cells.
PorBIA, which is the expressed por allele in gonococcal strains associated with
disseminated gonococcal infection, facilitates invasion of epithelial cells [247, 255]. The
PorBIA serotype is specifically associated with serum resistance [35] and was shown to
mediate resistance to the alternative and classical complement pathway through binding
of Factor H and C4b-binding proteins, respectively [189-190]. The PorBIB serotype is
also able to bind C4b-binding protein indicating that neisserial porins mediate stable
resistance to complement pathways [188].
C. Lipooligosaccharide (LOS)
Like most other Gram-negative bacteria, Neisseria express lipopolysaccharide
(LPS), which is the main component of the outer leaflet of the outer membrane forming
an essential barrier to the external environment. The structure of LPS is comprised of
Lipid A, a lipid moiety which anchors the molecule to the outer membrane, a short
oligosaccharide core, and a variable length repeating polysaccharide unit or O-antigen.
The LPS structure in pathogenic Neisseria, lacks the repeating O-antigen and so is
more accurately termed, lipooligosaccharide (LOS). Though the LOS structure is stably
expressed, glycosyl transferases, which mediate the addition of terminal sugars to the
LOS structure and are encoded by the lgt genes, are phase variable [80]. Phase
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variation of the glycosyl transferases occurs as result of slipped strand mis-pairing
during DNA replication due to a polyG tract within the coding region of lgt genes [270].
The combination of these enzymes results in the antigenic diversity and variable
expression of LOS terminal structures.
The oligosaccharide groups on LOS terminal structures are identical to the
oligosaccharides on host glycosphingolipids [92]. Specifically, the lacto-N-neotetraose
(LNnT) moiety mimics human paragloboside. In N. gonorrhoeae, the LNnT moiety of
LOS structures bind to the host asialoglycoprotein receptor to facilitate adherence to
human sperm [91] and invasion of urethral epithelial cells [90]. This example of
‘molecular mimicry’ indicates that neisserial LOS contributes to hijacking of host
receptor systems and immune evasion [92, 248].
LOS can be further modified by the addition of sialic acid moieties to the terminal
lactosamine of LOS. Neisseria cannot synthesize sialic acid, instead it utilizes host
derived cytidine 5′-monophospho-N-acetyl neuraminic acid (CMP-NANA) as a sialyl
donor and requires a sialyl transferase for the modification [212]. Because sialic acid
acceptor sites only exist on certain variants of LOS terminal structures, which are
regulated by the phase variable expression of glycosyl transferases, sialic acid
modification is also variable. Sialic acid modification mediates serum resistance and
specifically, the sialic acid moiety of LOS binds to Factor H, mediating phase variable
resistance to complement mediated killing [191, 261]. While sialic acid modification
contributes to serum resistance, it also inhibits invasion of epithelial cells indicating that
variation of LOS terminal structures can contribute to conversion between invasive and
serum resistant phenotypes [246]. The phase variation and modification of LOS terminal

12

structures implicate a much larger role in gonococcal pathogenesis beyond stabilization
of the outer membrane, essential for viability.
D. Opacity (Opa) proteins
Opacity (Opa) proteins are a family of Neisseria outer membrane proteins that
mediate invasion of epithelial cells and leukocytes [127, 154, 195, 256]. Opa proteins
were originally described for their capacity to impart opacity to the colonies that express
them [229]. While N. meningitidis encodes 4 opa loci, N. gonorrhoeae have 11 that are
dispersed throughout the genome [16, 219]. The selection of Opa+ gonococci during
natural and experimental infection [109, 230-231] is indicative of their important role in
gonococcal infection.
Expression of Opa proteins is subject to phase variation at the translation level
as a result of slipped-strand mis-pairing of a pentameric repeat sequence (5’-CTCTT-3’)
within the signal peptide of the coding region of the gene [219]. Thus, a gonococcus can
express one or multiple Opas at a time; however, expression of no more than 4 Opas
have simultaneously been detected in an individual gonococcus [22]. Opa proteins also
undergo antigenic variation due to recombination events between opa loci [97].
Opa proteins are ~ 30kDa in size and form eight stranded β-barrel structures with
four surface-exposed loops [250]. Loops 1, 2 and 3 are variable and the sequence
diversity in these regions confer receptor specificity. Opa proteins can be categorized
based on their receptor tropism. A small group of Opas bind to heparin sulfate
proteoglycans (HSPGs) and extracellular matrix proteins vitronectin and fibronectin,
while most Opas bind to the human carcinoembryonic related cell adhesion molecule
(CEACAM) family of receptors [60]. The combined phase and antigenic variation of Opa
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proteins provides important functional diversity via their recognition of specific cellular
receptors, which mediates tissue tropism and influences interactions with epithelial and
phagocytic cells.

VI. Iron in the human host
Iron is an essential element for most living organisms. Iron can exist in two
readily reversible redox states: ferrous, Fe2+ or ferric, Fe3+. Thus, it is incorporated as a
co-factor or electron carrier of a wide range of proteins, where it can adopt a redox
potential from -300 to +700mV depending on its local protein environment [9]. Ironcontaining proteins participate in essential physiological functions such as respiration
and DNA biosynthesis [9]. While the chemical properties of iron contribute to its
biological versatility, they also potentiate toxicity. In the presence of oxygen, the
reduced ferrous iron form is predominate and can activate the Fenton Reaction [Fe 2+ +
H2O2 = OH• + OH- + Fe3+], generating highly reactive free hydroxyl radicals that are
detrimental to most macromolecules [244].
Though the human body contains 3-4g total iron, iron is tightly regulated to
mitigate its potential toxicity. Storage proteins such as ferritin sequester iron
intracellularly while extracellular iron is carefully chaperoned through the body by carrier
protein transferrin. The presence of transferrin in plasma, lymph and cerebrospinal fluid
and lactoferrin in exocrine secretions purge the human host of free iron [258]. In normal
human plasma, free iron levels are ~ 10-18 M [177]. Thus, the human host is a hostile
environment for invading microorganisms that require micro molar amounts of iron for
growth. Additionally, host iron withholding defenses, also termed “nutritional immunity”,
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in response to infection further limit iron availability by reducing dietary iron absorption
and plasma iron levels and increasing intracellular iron storage [257]. The ability of
pathogenic microbes to acquire iron from host sources can therefore be considered a
critical virulence determinant. In the absence of free iron, host-derived iron binding
proteins can be biological iron sinks to invading microbes that are capable of utilizing
them. Some potential iron sources within the human host are briefly described below.
A. Transferrin
Transferrin (Tf) is an 80kDa glycoprotein whose primary role is to transport iron
throughout the body. Tf structure is bi-lobal (C- and N-lobe) and each lobe can bind an
iron atom, though the N-lobe appears to be predominately occupied by iron in vivo
[150]. Tf binds to Fe3+ with high affinity (Kd ~ 10-22 M). In serum, Tf is ~30% saturated
with iron and is present at substantial concentrations (25-44µM); however, only 0.21.3µM is present in mucosal secretions [209]. To facilitate iron trafficking, iron-laden Tf
binds to the human transferrin receptor (TfR1) expressed on the surface of all iron
requiring cells [2]. The Tf-TfR1 complex is internalized via receptor mediated
endocytosis and the endosome is subsequently acidified to release Fe 3+. Apo-Tf
remains associated with the TfR1 and the complex is recycled back to the cell surface
where Tf is released into serum [150].
B. Lactoferrin
Lactoferrin (Lf) is iron binding glycoprotein within the transferrin family. It is found
in highest abundance in milk, but it also present in other biological fluids including tears,
saliva, vaginal fluids, semen, nasal and bronchial secretions, bile, gastrointestinal fluids,
urine [79]. In serum, Lf is present at low levels (3.8-8.8nM), but is a significant
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component of mucosal secretions at 6-13µM [209]. Like Tf, Lf is ~ 80kDa, bi-lobal and
can bind Fe3+; however, unlike Tf, Lf retains bound iron in acidic conditions [68]. In
addition to roles in iron-sequestration, Lf has been attributed a number of other
physiological roles, one of which is innate immunity [79]. A significant amount of Lf is
found in the specific granules of polymorphonuclear leukocytes and has demonstrated
iron-independent antibacterial activity. Proteolytic processing of Lf results in the cationic
peptide lactoferricin, which is thought to interact with negatively charged structures on
the surface of bacteria such as LPS and contribute to disorganization of the outer
membrane resulting in cell lysis [68].
C. Ferritin
Excess iron is stored in the intracellular storage protein, ferritin. Ferritin is a
hetero-polymer comprised of 24 heavy and light polypeptide subunits that assemble to
form an almost perfectly spherical nano-cage [2]. The mature protein shell is ~450kDa
with a diameter of 8-12nm and can hold up to 4500 oxygen bound iron atoms [2, 96].
Iron is stored in the Fe3+ form in ferritin. Hemosiderin, a degradation product of ferritin
contains a heterogeneous iron mineralization products and can release iron in acidic
conditions [179].
D. Heme/ hemoproteins
Approximately 70% of the iron content in the human body is within heme, a
heterocyclic organic ring called porphyrin covalently bound to Fe2+ (heme) or Fe3+
(hemin) [203]. Heme solubilizes iron and enhances its catalytic activity; as such it is
incorporated as a prosthetic group of hemoproteins involved in oxygenation, oxidative
stress-response, electron transport, oxygen transport, oxygen sensing, and oxygen
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storage [10]. Over 95% of heme is in hemoproteins, the majority of which is in
hemoglobin found mainly within erythrocytes [203]. Hemoglobin (Hg) is a tetramer
comprised of two α- and two β- chains. Each subunit binds to a heme molecule, of
which the heme-iron can bind to oxygen to facilitate oxygen transport. Though
intracellular, Hg can be released via spontaneous hemolysis resulting in 80-800nM of
Hg in serum [209]. However, excess quantities of the tetrameric glycoprotein,
haptoglobin (Hp) rapidly complexes Hg and removes it from circulation by delivering it
the endocytic system via receptor-mediated endocytosis [173]. Likewise, any heme
dissociated from Hg during hemolysis is bound to the glycoprotein hemopexin (Hx) and
removed from circulation in a receptor-dependent manner [173].
E. Siderophores
In response to iron limitation many microorganisms (bacteria, yeast and fungi)
synthesize and secrete, small (<1kDa) iron chelating molecules termed siderophores
[193]. These siderophores specifically bind Fe3+ with Kd ~10-22-10-50 M and can thus
remove iron from host sources such as ferritin, Tf, Lf, but not from heme or
hemoproteins [193]. Most siderophores are biosynthetically produced by large multienzyme synthases and have a backbone of modified amino acid side chains creating
the iron-coordinating ligand [47]. They can be classified into one of three groups:
catecholate, hydroxamate and hydroxycarboxylate [252]. Upon secretion, siderophores
scavenge free or host protein bound iron in the extracellular environment. The ironladen siderophores can then deliver the sequestered iron to microorganisms that
express siderophore specific receptors.
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Mammals fight back against bacterial siderophores by producing the lipocalin
family of proteins termed siderocalins, for siderophore binding lipocalins. Siderocalins
include lipocalin 1 (Lcn1) or tear lipocalin and neutrophil gelatinase associated lipocalin
(NGAL or Lcn2, 24p3, Scn). These proteins bind enterobactin-like siderophores,
preventing bacteria from scavenging iron [54]. Some bacteria go further to modify their
siderophores via glycosylation, which prevents siderocalin binding [70].
Another variation of the siderophore theme are hemophores. Hemophores are
bacterial proteins that bind heme or host hemoproteins with high affinity. They are
structurally diverse and have different mechanisms of heme coordination. Like
siderophores, hemophores deliver heme back to the bacteria that secrete them via cell
surface receptors; however, only the heme moiety is internalized while the hemophore
is recycled at the cell surface [253].

VII. Iron acquisition systems of Neisseria gonorrhoeae
As an obligate human pathogen N. gonorrhoeae has evolved a diverse catalogue
of systems to assimilate iron from the hostile host. Unlike other bacteria N.
gonorrhoeae, does not secrete any siderophores [259]. Instead it relies on single and
two-component systems to acquire iron from host derived iron or heme binding proteins.
A. Two-component systems
A schematic of two-component systems for iron acquisition in N. gonorrhoeae
are depicted in Figure 1. The Tf-iron acquisition system is comprised of a TonBdependent transporter (TdT), TbpA and a surface exposed lipoprotein, TbpB. The
TbpA/B system is found in most Neisseria; notably it is found in all N. meningitidis and
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Figure 1. Two-component iron acquisition systems of N. gonorrhoeae.
Host iron sources transferrin (hTf), lactoferrin (hLf), hemoglobin (Hg), and hemoglobin
bound to haptoglobin (Hg-Hp) are shown in the extracellular space with their
gonococcal receptor systems. The TonB-dependent transporters (TbpA, LbpA and
HpuB) are depicted are as barrels traversing the outer membrane (OM) with a plug
domain occluding the barrel. The companion lipoproteins (TbpB, LbpB and HpuA) are
shown attached to the outer leaflet of the OM. The TonB/ExbB/ExbD system is shown
attached to or imbedded within the inner membrane (IM). TonB interacts with the plug
domain of TdTs to facilitate iron transport through the TdT barrel. The PBP, FpbA is
shown localized to the periplasm where it binds ferric iron from TbpA and LbpA and
shuttles it to the inner membrane permease, FbpB which transports iron into the cytosol
upon ATP hydrolysis by ATPase, FbpC.
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Figure 1. Two-component iron acquisition systems of N. gonorrhoeae.
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N. gonorrhoeae strains [155]. Additionally, the absence of the Tf acquisition system
attenuated virulence in a human male model of infection indicating the critical role of Tf
utilization to pathogenesis [52]. TbpA and TbpB are both encoded in an iron repressed
operon in which tbpB precedes tbpA. The structure of TbpA is consistent with the
common topology described for all TonB-dependent transporters: a β-barrel comprised
of 22 amphipathic β-strands, surface exposed loops and a globular plug domain inside
the barrel [175]. TbpB has a bi-lobal structure; the N- and C-terminal lobes can both can
bind Tf [62]. Both TbpB and TbpA can bind Tf with nanomolar affinities and remove its
iron [53, 211]. Only TbpA is required for uptake of iron from Tf, but the presence of
TbpB makes the process more efficient since TbpB preferentially binds holoTf [6, 50,
63].
The Lf acquisition system is analogous to the Tf acquisition system comprising a
TdT, LbpA, and a surface exposed lipoprotein, LbpB [18, 20, 208]. Like the Tf
acquisition system the lbpA/B genes are encoded on an iron repressed operon where
the lipoprotein precedes the TdT [4]; however, LbpB is subject to phase variation due to
a polyC-tract within the coding region [18]. The LbpA/B system is present in most
Neisseria [155]. While present in all N. meningitidis strains, the Lf acquisition system is
absent in half of gonococcal isolates due to a large deletion of lbpB and the 5’ end of
lbpA [4]. The Lf acquisition system is not required for virulence, as N. gonorrhoeae
lacking the LbpA/B are still able to cause infection in men [52].
The hemoglobin/ haptoglobin (Hg-Hp) acquisition system is another twocomponent acquisition system comprised of a TdT, HpuB, and a lipoprotein, HpuA
present in most Neisseria. Unlike the Tf and Lf systems, which specifically recognize
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human Tf or Lf, the HpuB/A system recognizes Hg, Hp or Hg-Hp complexes [42-43,
138, 140]. The system internalizes the heme moiety from Hg which can support use of
Hg or Hg-Hp as a sole source of iron or heme [141]. Both HpuB and HpuA are required
for Hg binding and growth in the presence of Hg as the sole iron source [42]. The
operon encoding hpuB and hpuA is iron repressed and phase varies by virtue of a
polyG tract within the coding sequence of hpuA [42, 139-140].
B. Single component systems
In addition to the two component systems described, Neisseria also encode
single component systems in which a TdT is the sole surface exposed component. The
HmbR receptor in N. meningitidis facilitates utilization of Hg and is subject to phase
variation by virtue of a polyG tract within its coding region [139, 197]. HmbR however, is
present in N. gonorrhoeae as a pseudogene due to a premature stop codon [197, 222].
FetA, another single component iron acquisition system, facilitates the utilization of
catechol-type siderophores and undergoes phase variation due to a polyC tract in its
promoter [36, 98]. TdfF is a TdT specific to pathogenic Neisseria [155, 214]. Its
expression has only been detected in iron repressed conditions in the presence of
serum [83, 238]. TdfF was found to be important for intracellular survival and is
hypothesized to facilitate utilization of an intracellular iron source though the ligand has
not been identified [83]. Gonococcal single component systems for iron acquisition are
depicted in Figure 2.
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Figure 2. Single component systems for iron transport in N. gonorrhoeae.
The TonB-dependent transporters (FetA and TdfF) are depicted are as barrels
traversing the outer membrane (OM) with a plug domain occluding the barrel. FetA
facilitates utilization of catechol-type siderophores secreted by neighboring bacteria
such as enterobactin (Ent, pictured in the extracellular space). The ligand to which TdfF
binds to support gonococcal survival in cervical epithelial cells is not known. The
TonB/ExbB/ExbD system is shown attached to or imbedded within the inner membrane
(IM). TonB interacts with the plug domain of TdTs to facilitate substrate transport
through the TdT barrel. The PBP, FetB is shown localized to the periplasm where it is
expected to bind ferric-siderophores and shuttle them to the putative inner membrane
permease encoded by fetCDEF. The putative PBP, FetB2 encoded near TdfF is
expected behave similarly to FetB.
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Figure 2. Single component systems for iron transport in N. gonorrhoeae.
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C. TonB-dependent transport
Subsequent to binding of host iron sources at the cell surface, transport of iron or
iron-chelate through TdTs requires metabolic energy provided by the TonB/ExbB/ExbD
complex localized to the inner membrane. In Neisseria, tonB, exbB and exbD are within
an operon and are iron-repressed [19, 64, 106, 224]. TonB has an N-terminal
transmembrane domain, a proline-rich spacer region that allows it to span the
periplasmic space and a C-terminal domain essential for interaction with TdTs [125].
The mechanism by which energy is transduced to the TdT on the outer membrane is
not fully resolved. TonB in complex with ExbB and ExbD harnesses energy from the
proton motive force [184] and is thought to transduce energy to TdTs via interaction with
the TonB box found on the plug domain of TdTs, resulting in movement of the substrate
through the channel and into the periplasm [125].
D. Cytoplasmic transport
Once in the periplasm, transport of iron or iron-chelates across the cytoplasmic
membrane requires an ATP-binding cassette (ABC) family transporter comprised of a
periplasmic binding protein (PBP), and inner membrane permease and ATP binding
domains [124]. The transport of iron from Tf and Lf into the cytoplasm requires FbpA,
the PBP of the FbpABC system that binds Fe3+ with a Kd ~ 10-18M [45, 211]. The
FbpABC operon is also iron repressed [64, 72, 106]. A heme ABC transport system is
hypothesized to exist in Neisseria but has not been identified. Enterobaction utilization
also requires the PBP, FetB of the putative ABC transporter FetCDEF, which are all
transcriptionally linked to FetA [36, 98].
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E. Regulation
All of the TdTs involved in iron/ iron-chelate acquisition are regulated by Fur.
Generally, Fur acts a repressor. In high iron concentrations Fe2+ binds to Fur, increasing
its affinity for the specific DNA binding motif, termed Fur box, within promoter of target
genes [28]. Fe/Fur binding to the Fur box blocks RNA polymerase recruitment inhibiting
transcription. Fur can also act positively on gene expression through direct and indirect
mechanisms [274]. FetA, for example is activated by MpeR [98], an AraC-like regulator
that is Fur repressed [106].
F. Uncharacterized TdTs in N. gonorrhoeae
Additional TdTs in N. gonorrhoeae whose functions have not yet been
characterized are listed in Table 1. These include TdfG, which is present only in N.
gonorrhoeae; TdfH, which found in most Neisseria and TdfJ, which is present in all
Neisseria [51, 155]. Of the TdTs characterized, the majority have roles in iron
acquisition and are iron repressed [206]. The uncharacterized TdTs of N. gonorrhoeae
are differentially regulated by iron. TdfG is iron repressed supportive of a role in
transport of iron or an iron chelate [64, 106, 238]. However, TdfH is not regulated by
iron, which may imply a function outside of iron acquisition [64, 238]. Transcriptional
studies indicate that tdfJ is iron-induced, which is also inconsistent with a role in iron
acquisition [64, 273]. The function of these receptors is further occluded by the fact that
their closest homologs are heme or siderophores receptors, though their contribution to
gonococcal heme utilization has not been demonstrated [51, 238]. Furthermore studies
in N. meningitidis have implicated TdfH and TdfJ in Zn and/or heme acquisition [126,
225-226], but these phenotypes have not been explored in N. gonorrhoeae.
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Table 1. Uncharacterized TdTs in N. gonorrhoeae
Name

Predicted size1

Closest homologs

Distribution2

Iron repression

TdfG

136kDa

Heme transporters

N. gonorrhoeae
only

Iron repressed

TdfH

104kDa

HasR and heme
transporters

Most Neisseria

Not iron
regulated

TdfJ

86kDa

Siderophore and
heme transporters

1Predicted

All Neisseria

Iron induced

molecular weight
indicates whether the gene is possessed by some or all Neisseria including
commensal species
2Distribution
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VIII. Vaccine Development
In light of the rising threat of untreatable gonorrhea, the need for novel therapies
and a protective vaccine is even more urgent. Gonococcal vaccine development
strategies have stalled due to the complications of antigenic variation of past vaccine
targets such as pili and porin during natural infection as well as the immunosuppressive
effects of natural infection [277]. However, recent insights have revealed that the active
suppression of adaptive immunity by N. gonorrhoeae can be reversed in vivo by adding
blocking antibodies against innate immunity-inducing cytokines, resulting in an antigonococcal immune response and protective immunity in a mouse model of female
genital tract infection [146-147]. These novel insights may propel forward vaccine
development strategies. As such, the identity of new potential vaccine targets remains
relevant.
The surface exposure, limited sequence variation and wide-spread distribution
among gonococcal strains indicate that TonB-dependent transporters may be good
potential vaccine targets. Past work has demonstrated that intranasal vaccination of
TbpA and TbpB conjugated to the B subunit of cholera toxin elicits mucosal and serum
antibodies that are bactericidal in the presence of human complement in the mouse
model of female genital tract infection [186]. Given the promising results with TbpA and
TbpB, the use of other TdTs as vaccine antigens may also be successful. For example,
ZnuD, the meningococcal TdfJ homolog, was shown to elicit cross reactive bactericidal
antibodies against genetically distinct meningococcal strains when used to immunize
mice and guinea pigs in an outer membrane vesicle vaccine formulation [103].
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IX.

Research Objectives
The goal of the research described in this thesis is to characterize the regulation

and function of the gonococcal TonB-dependent transporters TdfG, TdfH and TdfJ.
Three main objectives were pursued to achieve this goal. First, the role of these
receptors in gonococcal heme utilization was assessed. Next, the regulation of these
receptors in response to iron and zinc was explored. Additionally, the regulation of these
TdTs by known virulence regulators was evaluated. Finally, the contribution of TdfH and
TdfJ to gonococcal Zn acquisition was determined. These studies have ascribed
functions to TdfH and TdfJ and characterized a novel gonococcal defense strategy
against host mediated nutritional immunity. Additionally, these studies have identified a
novel regulator of TdfG and revealed strain specific regulation of TdfH. Together the
work described herein will provide insight into the contribution of these receptors to
gonococcal pathogenesis, which may be useful for the development of novel protective
and/or therapeutic strategies.
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Chapter 2: Materials and Methods

I. Bacterial strains and routine maintenance
Strains and plasmids used in this study are listed in Table 2. All plasmids were
propagated in E. coli TOP10 cells (Invitrogen). E. coli was cultured in Luria-Bertani (LB)
broth media [14-15] with antibiotic selection at 100µg/mL for ampicillin (Sigma), 34
µg/mL for chloramphenicol (Sigma), or 50µg/mL for kanamycin (Sigma). N.
gonorrhoeae was routinely maintained on GC medium base (GCB; Difco) agar with
Kellogg’s supplement I [118] and 12µM Fe(NO3)3 at 37ºC in 5% CO2 atmospheric
conditions. N. gonorrhoeae growth conditions for specific assays are described below.
II. Gonococcal mutant construction
A. TdT double mutants, MCV935 & MCV936
To generate double mutants incapable of expressing both TdfG and TdfJ or TdfH
and TdfJ in the FA1090 background, the XbaI and SacI flanked tdfJ fragment from
pVCU703 was first sub-cloned into pVCU403, which contains gonococcal DNA uptake
sequence [176]. The resulting plasmid, pVCU937, was subjected to random transposon
mutagenesis using the Ez-Tn5™<Kan-2> Kit (Epicentre). Kanamycin resistant clones
were screened via restriction mapping for Tn5<Kan-2>insertion within the tdfJ gene
fragment; the insertionally mutagenized plasmid employed subsequently was named
30

pVCU938. Gonococcal strains MCV660 and MCV661 contain an Omega insertion
within the coding region of genes tdfG and tdfH, respectively in an FA1090 background
and have been described elsewhere [83]. MCV660 and MCV661were transformed with
pVCU938 and transformants were selected on GCB agar supplemented with 50µg/mL
kanamycin. Chromosomal mutation was confirmed via PCR with MyTaq polymerase
(Bioline) according to manufacturer’s instructions. Primers used in this study are listed
in Table 3. The following pairs of gene specific primers were used: oVCU199/200, tdfG;
oVCU201/202, tdfH; oVCU203/204, tdfJ. The resulting strains were designated
MCV935 and MCV936.
B. Heme auxotrophic mutants
To generate heme auxotrophs in FA1090, tonB, and TdT mutant backgrounds
we obtained pUNCH1304, which contains the hemH gene disrupted with a
chloramphenicol acetyltransferase cassette (CAT) [237]. Gonococcal strains FA1090,
FA6916, MCV656, MCV660, MCV661, MCV662 and MCV935, which have been
described previously [52, 83, 169], were transformed with pUNCH1304 and
transformants were selected on GCB agar plates supplemented with 16µM hemin
(Sigma) and 1µg/mL chloramphenicol. Mutations were confirmed via PCR as previously
described with hemH specific primers oVCU793 and oVCU794 (Table 3). The resulting
strains, MCV937, MCV939, MCV943, MCV944, MCV945, MCV946 and MCV947 and
their genotypes are listed and Table 2.
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C. FA19 and FA1090 zur mutants, MCV963 & MCV964
To construct the gonococcal zur mutant, we obtained zur::kan from Dr. Alastair
G. McEwan at University of Queensland, which contains the full length zur gene in the
SmaI site of pUC19 interrupted by a kanamycin resistance cassette. This plasmid was
linearized with ScaI and used to transform gonococcal strains FA19 and FA1090.
Transformants were selected on GCB agar plates supplemented with kanamycin at
50μg/mL and the chromosomal mutation confirmed via PCR as previously described
with zur specific primers oVCU801 and oVCU802. The resulting strains were named
MCV963 (FA19 zur) and MCV964 (FA1090 zur).
D. tdfH complimented derivative, MCV956
Gonococcal strain MCV927 contains an Omega insertion within the coding region
of the tdfH gene in an FA19 background and has been described elsewhere [227]. To
generate a complemented derivative of MCV927, the full length tdfH gene including its
native ribosome binding site (RBS) was PCR amplified from FA1090 chromosomal DNA
using the following primers: oVCU807 and oVCU798. The amplicon was cloned into
pCR2.1 using the TOPO TA cloning kit (Invitrogen) according to manufacturer’s
instructions to generate pVCU944. The tdfH sequence was confirmed by sequencing
and pVCU944 was digested with restriction endonucleases ScaI and PmeI to isolate the
tdfH fragment, which was then purified and inserted at the PmeI site of pGCC4 [160].
The proper orientation of tdfH in the resulting plasmid, pVCU945, was verified by
restriction mapping with ScaI and KpnI. For gonococcal transformation, pVCU945 was
digested with NotI and the fragment containing tdfH, lctP, aspC and the erythromycin
resistance cassette was purified and used to transform MCV927. Transformants were
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selected on GCB agar plates supplemented with 1µg/mL erythromycin. The resulting
strain, MCV956, contains the chromosomal tdfH mutation and an ectopically inserted
copy of the wild type tdfH gene preceded by its native RBS under the control of a lac
promoter.
E. Opaless tdfH mutant, MCV955
A tdfH mutant in the FA1090 Opaless background [12] was constructed for NET
survival studies. To generate this mutant, the XbaI and SacI flanked tdfH fragment from
pVCU702 was sub-cloned into pVCU403. The resulting plasmid, pVCU947, was also
subjected to Ez-Tn5<Kan-2> random transposon mutagenesis, restriction mapped for
Tn5<Kan-2> insertion within the tdfH gene fragment and the insertionally mutagenized
plasmid was named pVCU948. FA1090 Opaless was then transformed with pVCU948
and transformants were selected on GCB agar supplemented with 30µg/mL kanamycin,
resulting in strain MCV955.
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Table 2. Strains and plasmids used in this study
Strain or plasmid Genotype and/or relevant characteristics

Ref. or source

N. gonorrhoeae
FA19

Wild type

[204]

FA1090

Wild type (ΔlbpA, HpuAB off)

[169]

Opaless

FA1090 ΔopaA-K

[12]

Δnuc

Opaless Δnuc (Kanr)

[115]

FA1090 misR

FA1090 misR::aphA-3 (Kanr)

Dr. William M. Shafer

FA19 misR

FA19 misR::aphA-3 (Kanr)

Dr. William M. Shafer

FA6916

FA1090 Δtbp

[52]

MCV304

FA1090 mpeR::aphA-3(Kanr)

[98]

MCV404

FA1090 fur-1 (Ermr)

MCV650

FA19 tonB::Ω (Strr, Spcr)

[227]

MCV656

FA1090 tonB::Ω (Strr, Spcr)

[83]

MCV660

FA1090 tdfG::Ω (Strr, Spcr)

[83]

MCV661

FA1090 tdfH::Ω (Strr, Spcr)

[83]

MCV662

FA1090 tdfJ::Ω (Strr, Spcr)

[83]

MCV926

FA19 tdfG::Ω (Strr, Spcr)

[227]

MCV927

FA19 tdfH::Ω (Strr, Spcr)

[227]

MCV928

FA19 tdfJ::Ω (Strr, Spcr)

[227]

MCV935

FA1090 tdfG::Ω tdfJ::Tn5 (Kanr, Strr, Spcr)

This Study

MCV936

FA1090 tdfH::Ω tdfJ::Tn5 (Kanr, Strr, Spcr)

This Study

MCV937

FA1090 tdfG::Ω tdfJ::Tn5 hemH::cat (Cmr, Kanr, Strr,
Spcr)

This Study

MCV939

FA1090 tdfJ::Ω hemH::CAT (Cmr, Strr, Spcr)

This Study

MCV943

FA1090 tdfG::Ω hemH:: CAT (Cmr, Strr, Spcr)

This Study

MCV944

FA1090 hemH:: CAT (Cmr)

This Study

MCV945

FA1090 tdfH::Ω hemH::CAT (Cmr, Strr, Spcr)

This Study

Dr. Aminat T. Oki
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MCV946

FA1090 tonB::Ω hemH:: CAT (Cmr, Strr, Spcr)

This Study

MCV947

FA1090 Δtbp hemH:: CAT (Cmr)

This Study

MCV955

FA1090 ΔopaA-K tdfH::Tn5

This Study

MCV956

FA1090 tdfH::Ω tdfHc(Ermr, Strr, Spcr)

This Study

MCV963

FA19 zur::kan (Kanr)

This Study

MCV964

FA1090 zur::kan (Kanr)

This Study

TOP10

F‒ mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15
ΔlacΧ74 recA1 araD139 Δ(ara-leu)7697galU galK
rpsL (Strr) endA1 nupG

Invitrogen

Rosetta™ (DE3)

F–ompThsdSB(rB– mB – ) galdcm (DE3) pRARE2 (Cmr
)

Novagen

pCR2.1 TOPO

Cloning plasmid (Kanr Ampr)

Invitrogen

pUC18

Cloning plasmid (Ampr)

Invitrogen

pGCC4

Complementation plasmid (Kanr Ermr)

pUC19zur::kan

pUC19 containing full length zur disrupted by Kan
cassette

pUNCH1304

pCRII derivative containing hemH::CAT

[237]

pETR7

pET24d(+) w/ rHusA (excl. signal peptide) + C-term.
thrombin cleavage site and 6xHis(Kanr)

[77]

pVCU403

pUC18 with gonococcal uptake sequence (Ampr)

[176]

pVCU702

pCR2.1 containing tdfH fragment

[83]

pVCU703

pCR2.1 containing tdfJ fragment

[83]

pVCU937

pVCU403 containing tdfJ fragment from pVCU703

This study

pVCU938

pVCU937 with tdfJ disrupted by Ez-Tn5<Kan-2>

This study

pVCU944

pCR2.1 containing full length tdfH + native RBS

This study

pVCU945

pGCC4 containing tdfH allele from pVCU944

This study

pVCU947

pVCU403 containing tdfH fragment from pVCU702

This study

E. coli

Plasmids
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[160]
Dr. Alastair G.
McEwan

pVCU948

pVCU947 with tdfH disrupted by Ez-Tn5<Kan-2>

This study

Amp, ampicillin; Cm, chloramphenicol; Erm, erythromycin; Kan, kanamycin; Spc,
spectinomycin; Str, streptomycin
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Table 3. Primers used in this study
Primer

Target

Sequence

oVCU199

tdfG

5′-GGC GCA TTG GCT TTT GCA GAC ACC CCG AAC-3′

oVCU200

tdfG

5′-GGC GCA TTG GCT TTT GCA GAC ACC CCG AAC-3′

oVCU201

tdfH

5′-GGC AGC GAG GCG CAG ATA CAG GTT TTG GAA-3′

oVCU202

tdfH

5′-GCG CCA GGT TTT CCC GCC AGC TTT TAT CAT-3′

oVCU203

tdfJ

5′-CCC CTC CTC GCC CAA GCG CAT GAA ACT GAG-3′

oVCU204

tdfJ

5′-GGC GTG GCA ATC ATC GTA TTC GTG GCT GTG-3′

oVCU793

hemH

5’-CGC AAA CCG CAT TAC CTG AT-3’

oVCU794

hemH

5’-ATT GGC TTT GGA ACG ATA CG-3’

oVCU798

tdfH

5’- CAC AGT TTA AAC AAA CGC GGG CTG-3’

oVCU801

zur

5’-TCA GTA CTA CCG CCT CCT GTC GT-3’

oVCU802

zur

5’-GTC GTT TAA ACA GGT GGG ACT TTG GT-3’

oVCU807

tdfH

5’- GGG CAG TAC TGA GGA AAA TAT GAG ATC T-3’
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III. Limited heme growth assays
For limited heme growth in Wade-Graver (GW) media, GW media was prepared
as previously described [251] except that Supplement A was treated with Chelex-100
(50g per 500mL) before being added at a 1:2 v/v ratio to normal strength M199 (Sigma
Aldrich). Gonococcal strains were first grown in the partially chelexed GW media until
log-phase growth was achieved. At log phase, gonococci were diluted to OD 600 of 0.02
in fresh partially chelexed GW media and transferred to a 96-well micro titer plate. Each
well was supplemented with iron specific chelator, Desferal (deferroxamine mesylate;
Sigma Aldrich) and hemin to a final concentration of 10µM and 5µM, respectively and
contained a total volume of 100µL. Hemin stock solutions of 5mg/mL were made in
0.1M NaOH, filter sterilized (0.22µm) and stored at 4°C in the dark. The micro titer plate
was incubated at 37°C and 5%CO2 with vigorous shaking and OD600 readings were
collected every 2 hours for 6 hours. For determination of viable bacteria, 20µL of culture
were recovered from wells, serially diluted, and spot platted onto GCB agar plates. After
incubation overnight at 37°C and 5%CO2, CFU of recovered gonococci were
enumerated.
Individual colonies of heme auxotroph mutants from GCB agar plates
supplemented with 16µM hemin were grown in chemically defined media treated with
Chelex 100 (Bio-Rad), CDM, [259] supplemented with 1µM heme until log-phase growth
was achieved. At log phase, cultures were diluted to OD600 of 0.02 in fresh CDM and
transferred to a micro titer plate. Each well was supplemented with hemin at a final
concentration of 5µM. The micro titer plate was incubated at 37°C, 5% CO 2 and growth
as monitored via OD600 readings every 2 hours for 6 hours.
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IV. Expression and purification of P. gingivalis hemophore, HusA
The plasmid pETR7, which contains recombinant HusA, P. gingivalis
hemophore like protein was obtained from Dr. Neil Hunter at Westmead Centre for Oral
Health and has been described previously [77]. Starter cultures of E. coli expression
strain Rosetta™ (DE3) containing pETR7 were grown in LB broth media with kanamycin
(LB-Kan) overnight at 37°C with vigorous shaking. The following day, starter cultures
were centrifuged at 4,000 x g for 10 minutes and the bacterial cell pellet was resuspended in fresh LB-Kan. The entire starter culture was used to inoculate 1L of LBKan, which was grown in at 37°C with vigorous shaking until an OD600 of 0.6 was
achieved. IPTG was then added at a final concentration of 0.5mM to induce protein
expression for 3 hours. After induction, bacterial cells were harvested by centrifugation
at 5,000 rpm for 30 minutes at 4°C. Cell pellets were washed with sterile 1X PBS, pH
7.2 and centrifuged at 5,000 rpm for 15 minutes. Supernatants were discarded and cell
pellets were dried, weighed and stored at -80°C overnight.
For protein purification, bacterial pellets were thawed on ice an re-suspended in
cold native lysis buffer (50mM NaH2PO4, 300mM NaCl, 10mM Imidazole [pH 8.0]) at
5mL buffer/1g pellet. 1X Protease Inhibitor Cocktail (Roche) and 1mg/mL lysozyme was
added before cultures were incubated for 30 minutes on ice. The cellular mixture was
sonicated (5x, 30 sec pulse, 1 minute pause between pulses) and the lysate centrifuged
at 10,000 rpm for 20 minutes at 4°C to remove debris. The cleared lysate was then
incubated with pre-washed 50% Ni-NTA agarose resin (Qiagen) overnight at 4°C. On
following day, the loaded Ni-NTA resin was packed into a polyprep column (Bio-Rad)
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and the flow through collected. The column was washed twice with 5mL wash buffer
(50mM NaH2PO4, 300mM NaCl, 20mM Imidazole [pH 8.0]) that was collected. The
recombinant protein was eluted from the column with elution buffer (50mM NaH 2PO4,
300mM NaCl, 250mM Imidazole [pH 8.0]). The column was rinsed with 1X PBS before
all sample fractions were stored at 4°C until SDS-PAGE analysis. Protein
concentrations of eluted samples were determined using the BCA Protein Assay Kit
(Pierce) according to manufacturer’s instructions. Before use in growth assays, purified
rHusA protein, was loaded with heme (2:1 molar ratio) and un-bound heme was
removed by dialysis (250mM NaCl, 100mM Tris [pH8.0]).

V. Hemophore utilization assay
CDM agarose plates treated with 10µM Desferal to chelate excess iron were
inoculated with gonococcal strains using a sterile Darcon swab (Puritan). A sterile
pipette was used to bore wells into the solidified media. Subsequently, 20µL of various
iron solutions including heme loaded HusA at indicated concentrations were added to
each well before incubation at 37°C in 5%CO2 atmosphere overnight. The following day,
plates were recovered and evaluated for growth around each iron source.

VI. Bacterial growth conditions for regulation studies
A. Iron replete and depleted conditions
Gonococcal strains were grown in GCB broth containing Supplement I until logphase growth was achieved. At log-phase, 24µM Fe (NO3)3 or 100µM Desferal were
added for iron replete and depleted conditions, respectively. All liquid cultures were
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grown at 37ºC with 5%CO2. Cultures were grown for 2 hours at the described condition
before whole cell lysates were harvested.
B. Varied Zn concentrations
Gonococcal strains were grown in CDM until log phase growth was achieved. At
log-phase cultures were before back diluted and Fe(NO3)3, ZnSO4 and/or Zn specific
chelator N,N,N’N’-Tetrakis-(2pryidylmethyl)-ethylenediamine (TPEN; Sigma) were
added at the stated concentrations and grown for 4 hours before whole cell lysates were
harvested. Stock solutions of TPEN were dissolved in 100% ethanol and stored at 20°C. Subsequent working solutions were diluted in deionized water, filter sterilized
(0.22µm) and stored short-term at 4°C.
C. Zn replete and depleted conditions
Gonococcal strains were grown in GCB broth media containing Supplement I
until log-phase growth was achieved. At log phase, ZnSO4 or TPEN were added at a
final concentration of 25µM for Zn replete and depleted conditions, respectively.
Cultures were grown for 4 hours at the described conditions before whole cell lysates
were harvested.

VII. Protein analysis methods
A. Whole cell lysate preparation
Gonococcal whole cell lysates were collected by centrifuging cultures of
standardized density at 21, 000 x g for 10 minutes; gonococcal cell pellets were then re-
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suspended in Laemmli solubilizing buffer [128] and stored at -20°C until use.
Immediately prior to SDS-PAGE, whole cell lysates were treated with 5% βmercaptoethanol, drawn through a 28-gauge syringe to reduce viscosity and boiled for 3
minutes.
B. SDS-PAGE and Coomassie stain
Protein samples were resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) on 7.5% or 15% polyacrylamide gels using a Mini-Protean
III apparatus (Bio-Rad). To detect purified proteins, SDS-PAGE gels of separated
proteins were stained with Coomassie blue (0.25% Coomassie R-250, 50% methanol,
10% glacial acetic acid) for 1 hour and de-stained in 20% methanol and 5% acetic acid
overnight at room temperature to minimize background staining.
C. Western blot analysis
Proteins separated on SDS-PAGE gels were transferred to nitrocellulose
membranes (GE Healthcare Life sciences) in 20mM Tris base, 150mM glycine and 20%
methanol [234] in a submerged transfer apparatus (Bio-Rad) at constant current of
28mA for 16 hours. Membranes were stained with Ponceau S solution (0.1% w/v
Ponceau S, 5% acetic acid) for 10-12 minutes to confirm equal protein loading of lanes
before immunodetection of specific proteins. For TdfG detection, membranes were
blocked with 5% bovine serum albumin (BSA) in a high salt Tris-buffered saline (TBS)
(20mM Tris, 500mM NaCl, [pH 7.5] 0.05% Tween 20), probed with polyclonal antiserum
against TdfG [238] and washed with high salt TBS followed by incubation with
secondary antibody conjugated to alkaline-phosphatase (AP) (Bio-Rad). Blots were
developed with the nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-342

indolylphosphate (BCIP) system (Sigma). For TdfH detection, membranes were blocked
with 5% BSA in a high salt TBS, probed with polyclonal antiserum against TdfH [238]
and washed with high salt TBS followed by incubation with AP conjugated secondary
antibody. Blots were developed with NBT/BCIP. For TdfJ detection, we generated
polyclonal anti-peptide antibodies (New England Peptides) against regions predicted to
correspond to Loop 2 (sera 116, 117) and Loop 5 (sera 118, 119) after alignment of
TdfJ to a 2D-topology model of TbpA. Membranes were blocked with 5% skim milk in a
low salt TBS (50mM Tris, 150mM NaCl, [pH 7.5]), probed with serum 117 and washed
with low salt TBS before being incubated with secondary antibody conjugated to
horseradish peroxidase (Southern Biotech). Blots were developed with Pierce-ECL-2 kit
(Thermo Scientific). For TbpB detection, rabbit anti-TbpB primary antibody [185] was
used after blocking with 5% skim milk. Blots were then washed with low salt TBS before
incubation with secondary antibody conjugated to AP and developed with NBT/BCIP.

VIII. Enumeration of bacterial growth in Zn replete and depleted conditions
Gonococci were grown until log-phase growth was achieved in Zn restricted rich
media, GCB broth containing Supplement I, 12µM Fe(NO3)3 and 12.5µM TPEN (GCB +
supplement I, Fe, TPEN). At log phase, cultures were back-diluted and were not further
treated to represent Zn depleted conditions or were treated with ZnSO4 (18.75μM) for
Zn replete conditions. After growth for 6hours, bacterial cells were harvested by
centrifugation at 4,000 x g for 15minutes at 4ºC, washed twice with cold PBS, 1mM
EDTA and re-suspended in PBS before being serially diluted and spot plated on GCB
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agar plates supplemented with V-C-N Inhibitor (BD BBL™). Plates were incubated at
37ºC and 5% CO2 for 16 hours before CFUs were enumerated.

IX. Calprotectin growth assay
Purified recombinant human calprotectin (CP) was obtained from Dr. Walter
Chazin at Vanderbilt University. CP was stored in 20mM Tris pH 8.0 100mM NaCl
10mM β-mercaptoethanol buffer solution and kept at -80°C. Aliquots were thawed on
ice immediately prior to use and stored short-term at 4°C to prevent multiple freezethaw cycles. For CP growth assays, gonococci were first grown in CDM until log phase
growth was achieved. At log phase, cultures were diluted to OD600 of 0.02 and
transferred to a 96-well micro titer plate. Each well contained 7.5μM 30% saturated
human transferrin (hTf) as the sole iron source, 2.5μM apo-bovine transferrin (bTf) to
sequester residual iron and 1μM TPEN for Zn chelation. In some cases, 2mM IPTG was
also added to induce TdfH expression in MCV956. Some wells were further
supplemented with either CP+ Zn (10µM CP, 5µM ZnSO4) or 5µM ZnSO4 alone. The
micro titer plate was incubated at 37ºC and 5% CO2 with vigorous shaking and OD600
readings were collected every 2 hours for 6-8 hours.

X. Whole cell calprotectin binding assay
Gonococcal strains were grown in CDM treated with 24μM Fe(NO3)3 until logphase growth was achieved. At log phase, cultures were back-diluted and 1μM TPEN
was added. 2mM IPTG was also added when indicated to induce TdfH expression in
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MCV956. Cultures were grown in the described conditions for 4 hours before being
applied to nitrocellulose membranes using a dot-blot apparatus (Bio-Rad). Dried
membranes were blocked for 1hour with 5% skim milk in low salt TBS before being
incubated with CP + Zn (0.17µM CP, 0.01µM ZnSO4) in blocker. After washing with low
salt TBS, blots were probed for CP using rabbit anti-s100A9 polyclonal antibody
(Thermo-Scientific) and secondary antibody conjugated to AP. Dot blots were then
developed with NBT/BCIP. For densitometry, replicate blots were scanned and
intensities of individual dots were quantitated using NIH ImageJ [207]. Quantitated
intensities were normalized to wild type and expressed as % CP binding.

XI. Zn accumulation assay
Gonococcal strains were first grown in Zn restricted rich media(GCB +
supplement I, Fe, TPEN) until log-phase growth was achieved, at which point cultures
were back diluted and either treated with 18.75μM ZnSO4 (Zn replete) or no further
addition (Zn deplete). For Zn accumulation in the presence of CP, cultures were treated
with CP + Zn (2µM CP, 1µM ZnSO4) after back dilution. Cultures were grown for 6
hours in the described conditions before cells were harvested by centrifugation at 4ºC
for 15 minutes at 4,000 x g and washed twice with cold, chelexed PBS supplemented
with 1mM EDTA. Bacterial cells were then re-suspended in undiluted Trace Metal
Grade Nitric Acid, heated at 95ºC for 2 hours, and cooled at room temperature
overnight. For analysis, samples were diluted 12.5 or 22-fold in chelexed deionized
water. Metal composition was determined using an MPX Vista Inductively Coupled
Plasma-Optical Emission Spectrometer (Varian, Inc.). To determine the concentration of
45

metals associated with the cells, a standard curve was generated with a 10μg/mL multielement standard (CMS-5; Inorganic Ventures) diluted in chelexed deionized H2O and
then serially diluted twofold in 1% nitric acid to generate dilutions ranging from
0.640µg/mL to 0.020µg/mL. Cell pellets from parallel cultures were re-suspended in
PBS, treated with 5% SDS and vortexed for 30 sec for lysis. Protein concentrations
were determined using BCA kit.

XII. NET survival assay, performed in the laboratory of Dr. Alison Criss at
University of Virginia
Neutrophils were purified from venous blood collected from healthy donors
according to a protocol approved for use in the laboratory of Dr. Alison Criss by the
University of Virginia Institutional Review Board for Health Science Research. Viable
exponential-phase gonococci were obtained by sequential dilution in rich medium as
previously described [55] except at the final dilution, cultures were re-suspended in
phenol red-free Roswell Park Memorial Institute (RPMI) with 1μM TPEN and grown to
an OD550 of 0.4. Bacterial suspensions were then centrifuged at 10, 000 x g for 3
minutes and washed once with RPMI before exposure to neutrophils. Survival of
gonococcal strains upon exposure to PMA stimulated neutrophils treated with
cytochalasin D only or cytochalasin D plus DNase I, was determined as previously
described [115]. Briefly, neutrophils were seeded in 24-well plates and treated with
20nM PMA for 15 minutes at 37°C in 5% CO2. One set of wells was treated with
10µg/mL cytochalasin D (Sigma), while another set was treated with cytochalasin D and
1 U of DNase I for, each for 15 minutes. Neutrophils were then exposed to Opaless
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parent, MCV955 (tdfH) or Δnuc gonococci grown as described above at a multiplicity of
infection (MOI) of 1 for 1 hour. After infection, well contents were serially diluted and
plated for CFU enumeration. Bacterial survival is expressed as a percentage of the
initial inocula per well.

47

Chapter 3: The role of TonB-dependent transporters: TdfG, TdfH and TdfJ in
heme acquisition

I. Introduction
As an essential co-factor for many enzymes functioning in crucial cellular
processes within all kingdoms of life, iron is an indispensable nutrient for most
organisms. In aerobic conditions, iron is present in the ferric (Fe3+) oxidized form but is
poorly soluble. The reduced ferrous (Fe2+) form is much more soluble but can catalyze
the production of free oxygen radicals which are highly toxic to macromolecules through
the Fenton reaction. As such, iron levels are tightly controlled to maintain iron
homeostasis in vertebrates and free iron is scarce. Instead, iron is sequestered
intracellularly by the iron storage protein ferritin and heme bound to hemoproteins.
Extracellular iron is in the ferric form and is tightly bound to iron transport protein
transferrin as well as lactoferrin present in mucosal secretions [209]. For a bacterial
pathogen to colonize a mammalian host, it must be able to assimilate iron from one or
more these host iron sources [254].
Approximately 70% of the iron within the human body is bound to heme [203].
Heme solubilizes iron and increases its catalytic ability: a property harnessed as the
prosthetic group of intracellular hemoproteins such as hemoglobin (Hg), myoglobin and
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cytochromes to function in electron transport as well as oxygen transport, sensing and
storage [10]. Heme itself can be toxic due to its chemical properties and ability to
partition into lipid membranes [221]. Thus, free heme is rarely available in vertebrate
hosts. Small amounts of extracellular heme can be found in blood Hg from lysed
erythrocytes [173]. However, Hg is rapidly bound by serum protein haptoglobin (Hp)
[105]. The Hg-Hp complex is cleared from serum in a receptor mediated mechanism by
monocytes that express receptor CD163 [173]. The globin components of the Hg-Hp
complex are degraded in the lysosome and the heme detoxified while CD163 is
recycled to the plasma membrane to continue to function in Hg clearance and thus
mitigation of heme-mediated oxidative damage [173]. Likewise, free heme dissociated
from hemoglobin or other hemoproteins is tightly bound by various serum heme binding
proteins including high and low density lipoprotein (HDL and LDL, respectively), serum
albumin, hemopexin (Hx) and α1-microglobulin [11]. Similar to Hg-Hp clearance, Hx
facilities free heme uptake and subsequent degradation upon interaction with receptor
CD91, which triggers receptor mediated endocytosis in macrophages and hepatocytes
[11].
Despite the rapid recycling of heme and Hg from serum, 80-800nM of Hg can be
found in plasma [209] and can be a significant source of iron, albeit protein bound and
heme associated. Thus, pathogenic bacteria have developed strategies to assimilate
iron from heme/ hemoproteins. Bacterial heme acquisition systems can be classified
into two categories. The first category relies on the secretion of hemophores, bacterial
hemoproteins that scavenge heme from the extracellular environment that is then
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relayed back to the bacteria through specific receptors. The second category involves
receptors that directly bind to heme or host heme-containing proteins [254].
The secretion of hemophores is mostly limited to Gram-negative bacteria but has
been described in one Gram-positive pathogen, B. anthracis [10, 66]. Hemophores are
bacteria-derived proteins that are secreted into the extracellular milieu where they bind
free heme or host hemoproteins with high affinity. There are two types of hemophores
described for Gram-negative bacteria: the HasA-type, which has been described in
pathogens, S. marcescens, P. aeruginosa, P. fluorescens, and Y. pestis [10], or HxuA,
which is only found in H. influenzae. HasA-type hemophores capture free heme or
heme from host hemoproteins. Since HasA has higher affinity for heme than host
hemoproteins, heme is thought to passively transfer from host hemoproteins to HasA
[253]. Upon interaction with its specific outer-membrane receptor, HasA delivers heme
to the bacterial cell surface and only the heme molecule is internalized [253]. HxuA
binds to the serum heme recycling protein, hemopexin (Hx) to provide heme from the
heme-hemopexin complex. Unlike HasA, HxuA does not display high affinity heme
binding [73]. Instead, it liberates heme from Hx without heme capture inactivating the
biological function of Hx [253]. The released heme is then accessible to the nearby
receptor that facilitates its transport across the outer-membrane. Both HusA and HxuAtype hemophores require outer membrane receptors for heme internalization. The
receptors are TonB-dependent transporters consisting of a transmembrane β-barrel with
22 antiparallel β-strands, extracellular loops that interact with heme/ hemoprotein/
hemophore ligand and an N-terminal plug domain that closes the β-barrel pore. The
transport of heme across the outer membrane requires energy from the
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TonB/ExbB/ExbD system, so all receptors also contain a “TonB box” motif in the plug
domain, through which TonB and the receptor interact.
In direct heme acquisition systems, the TonB-dependent transporter itself directly
binds to heme and/or host hemoproteins. These TdTs can be substrate specific,
recognizing only one type of host hemoprotein like the Hg-Hp utilization proteins of H.
influenzae, P. gingivalis, and pathogenic Neisseria [233]. A subset of these substrate
specific TdTs are bipartite systems that include a lipoprotein in addition to the TdT for
utilization of the host hemoprotein as is described for pathogenic Neisseria and P.
gingivalis [253]. Other direct heme acquisition systems are non-specific and thought to
directly interact with heme to support heme assimilation from free heme as well as a
variety of host hemoproteins as is the case for HemR of Y. enterolitica and its
homologues in B. pertussis, S. dysenteriae, V. cholerae, C. jejuni, B. quintana, and E.
coli O157:H7 [10]. Over 30 heme receptors have been well-characterized in Gramnegative bacteria that share a range of sequence similarity anywhere from 20-90%
[210] indicating a wide range of sequence diversity. Most share a highly conserved
amino acid motif “FRAP(10X)H(XX)NPNL(2X)E”, which contains an invariable His
residue thought to coordinate heme [27, 223]. However, some heme TdTs lack this
motif indicating that additional mechanisms of heme coordination exist [203, 233]. To
fully optimize heme utilization from a variety of host heme sources bacteria can adopt
either of two strategies: expression of a heme acquisition system that has broad
specificity to a variety of heme sources or expression of multiple receptors for different
hemoproteins.
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After transport across the outer membrane of Gram negative-bacteria via TdTs,
heme is localized in the periplasmic space. ATP-binding cassette (ABC) transporters
facilitate the transport of heme from the periplasm to the cytosol. These transporters are
usually comprised of a high affinity periplasmic binding protein (PBP) that shuttles heme
through the periplasm to an inner membrane permease, through which heme is
transported to the cytoplasm upon ATP-hydrolysis [203]. The ABC transport system is
usually encoded within the same operon of the TonB-dependent transporter. Additional
components of the operon may encode cytoplasmic heme binding proteins which can
sequester heme and prevent it from catalyzing reactive oxygen species like ShuS of S.
dysenteriae or shuttle heme to degradative enzyme HemO like PhuS of P. aeruginosa
[203]. Heme oxygenase, encoded by hemO, which is ubiquitous in nature, catalyzes the
oxidation of heme into biliverdin, carbon monoxide, and free iron and is critical for iron
assimilation from heme and for mitigating heme toxicity [10, 233].
Pathogenic Neisseria express receptors that directly utilize heme from host
hemoproteins. The HpuB/A system is expressed in both N. meningitidis and N.
gonorrhoeae. It is comprised of a TonB-dependent transporter, HpuB, and a lipoprotein,
HpuA, analogous to the bipartite neisserial transferrin acquisition system [138, 140].
These genes are co-transcribed in a bi-cistronic operon and are subject to phase
variation [43, 140]. The HpuB/A system facilitates utilization of Hg or the Hg-Hp complex
and requires expression of both the lipoprotein and the TdT for Hg utilization [42].
Pathogenic Neisseria also encode HmbR, another phase-variable TonB-dependent
transporter that utilizes only Hg as an iron source; however, it is only expressed in N.
meningitidis due to a pre-mature stop codon in N. gonorrhoeae [197, 222]. Pathogenic
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Neisseria cannot utilize heme from Hx or albumin though it is capable of robust growth
in presence of free heme [65]. A heme ABC transport system has long been postulated
in Neisseria but has yet to be identified. Genome searches have not revealed an
obvious heme PBP or ABC transport system [198]. FbpA, a PBP, which is critical for the
use of iron from transferrin (Tf), lactoferrin (Lf), and Hg is not required for heme
utilization in Neisseria [119, 237]. In pathogenic Neisseria, the hemO gene, encoding
heme oxygenase, is upstream of the HmbR receptor and their expression is
transcriptionally linked. HemO was found to be critical for the use of all heme
compounds and for the mediation of heme toxicity [278].
Neither HmbR, HpuB/A, nor TonB are required for the utilization of free heme
[19, 43, 222, 224]. TonB-independent heme utilization is suggestive of heme passively
diffusing across the outer-membrane, possibly through the use of porins; but TonBindependent heme uptake may not be relevant in vivo as large amounts of heme are
rare in mucosal environments [209]. Thus, the existence of a free heme receptor has
been speculated in pathogenic Neisseria for some time. Heme-binding proteins
(HmBPs) isolated from both N. gonorrhoeae and N. meningitidis were suggested to be
heme specific receptors given the ability of a monoclonal antibody directed against the
97kDa HmBP to inhibit growth in the presence of heme [131-132, 134]. The genes
encoding the 97 and 44kDa HmBPs proteins have never been identified, though these
proteins may be the HpuB/A proteins given their similar size and similar heme binding
and inhibition profiles [44, 132].
There is no evidence that N. gonorrhoeae produces a hemophore, but it may still
be able to utilize bacterial derived hemophores as it capable of utilizing bacterial derived
53

siderophores via the TdT, FetA [36, 98]. Gonococcal infection occurs at mucosal
epithelia, primarily of the urogenital tract a host niche rich in both normal and sometimes
pathogenic bacteria. The female genitourinary tract, for example, contains commensal
bacteria which help to protect against pathogenic [142]. Bacterial vaginosis (BV), a
condition in which there is an imbalance between normal ‘good’ and abnormal bacteria,
is characterized by an increase in vaginal pH and BV-associated bacteria including
Mycoplasma hominis, Gardnerella vaginalis, Prevotella spp., Mobiluncus spp., and
Leptotichia/Sneathia [144]. BV has been demonstrated to be a risk factor for N.
gonorrhoeae infection [263] but the molecular mechanisms underlying the increased
risk have not been identified. Some BV-associated bacteria are cytotoxic and so can
help to liberate intracellular nutrients like heme bound to hemoproteins and provide
these to invading microbes. G. vaginalis, for example, has been shown to secrete a
hemolysin, termed vaginolysin with lytic activity specific to human erythrocytes,
neutrophils, and endothelial cells [271]. Sneathia amnii was also reported to have weak
hemolytic activity and to encode 2 putative hemolysins [93]. Bacteroidetes species
including Prevotella and Porphyromonas are also heme auxotrophs and thus encode
hemolysins as well as heme acquisition systems to fulfill this nutritional requirement
[137, 275]. Thus, it is possible that the cytotoxic and hemolytic activity of BV-associated
bacteria can provide an environment favorable to gonococcal infection by either
increasing the abundance of host hemoproteins or even providing bacterial derived
hemoproteins.
The role of heme iron utilization in gonococcal pathogenesis is difficult to
ascertain since expression of known hemoglobin receptors is phase variable and the
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gonococcus can assimilate iron from other host derived sources. Menstruation is
however a major risk factor for complicated gonococcal infection as half the number of
affected women reported DGI symptoms within seven days of the onset of menses
[196]. It is likely that strategies that contribute to the utilization of heme and
hemoproteins during menses, when the levels of host heme sources are presumably
elevated in the female genital tract, could contribute to pathogenesis. Indeed, the
expression of the HpuB/A system and utilization of Hg and Hg-Hp was found to be
correlated to the onset of menses in a study examining naturally occurring gonococcal
infection [5]. These results suggest a selective advantage for gonococci expressing
HpuB/A in the female genital tract during menses and point to the need to characterize
any additional receptors that may contribute to heme utilization.
Given their reported homology to known heme receptors N. gonorrhoeae TdTs
(TdfG, TdfH and TdfJ) have all been suggested to participate in heme utilization since
their identification in genome annotations [126, 238]. Table 4 summarizes the data
reported in the literature on their potential role in heme acquisition. Turner et al.
assessed the role of TdfG and TdfH in heme acquisition and reported that isogeneic
mutants unable to express TdfG or TdfH demonstrated no defect in their ability to grow
with heme as the sole iron source compared to parent strains [238]. Additionally,
expression of TdfH in an E. coli hemA mutant did not restore heme utilization [238]. E.
coli hemA is a heme auxotroph incapable of de novo heme synthesis and therefore
requires uptake of exogenous heme through a heme receptor to support growth in the
presence of heme. The ability of putative heme receptors to restore growth in the
presence of heme upon expression in E. coli hemA has served as positive indication of

55

Table 4. Summary of reported TdT heme phenotypes
Gene, species

Growth w/
heme1

Restores heme
utilization in E.
coli hemA

Binds
heme2

Ref.

tdfG, Ng

+

NR

NR

[238]

tdfH, Ng

+

-

NR

[238]

znuD, Nm

+

+

+

[126]

Ng, N. gonorrhoeae; Nm, N. meningitidis; NR, not reported
1Isogenic mutants were tested for their growth with heme as the sole iron source.
2Recombinant ZnuD was tested for its ability to bind hemin in vitro.
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function as a heme receptor [27, 224]. TdfH was also thought to be one of the hemin
affinity purified HmBPs, but failure of monoclonal antibody directed against the 97kDa
HmBP [134] to specifically detect TdfH, conclusively ruled out that possibility [238].
TdfJ, identified later as another gonococcal TdT [83], has been investigated for its
contributions to heme utilization. Though uncharacterized in the gonococcus, the
meningococcal TdfJ homologue, ZnuD was not required for growth in the presence of
heme, but could restore heme utilization and growth when expressed in E. coli hemA
[126].
In light of inconsistent findings implicating TdfJ in heme acquisition, we revisited
the contributions of TdfG, TdfH and TdfJ to gonococcal heme utilization. The studies
presented herein address three main points in an attempt to resolve gaps in the
literature with regards to the role of these TdTs in gonococcal heme utilization. First, we
address the possibility that N. gonorrhoeae may express functionally redundant
receptors for heme utilization. Since, the TdfJ homologue in N. meningitidis has an
observable heme phenotype we generated double mutants unable to express TdfJ and
TdfG or TdfH and assessed their ability to grow in the presence of heme. We expected
that if these receptors contribute to heme utilization, double mutants would be defective
for growth in limited heme conditions. Next, we restricted gonococcal growth to
exogenous heme uptake in an attempt to maximize TonB-dependent heme uptake
mechanisms and resolve the potential contribution of the aforementioned TdTs. To do
this, we generated tonB and TdT mutants in a gonococcal heme auxotrophic
background. We expected that growth under limited heme conditions would require
TonB and TdT-dependent mechanisms. Finally, we address the possibility that TdfG,
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TdfH, or TdfJ may facilitate the utilization of a “xeno-hemophore”. We identified a
potential candidate hemophore and tested its ability to support gonococcal growth as
the sole iron/ heme source. We expected that gonococcal growth in the presence of the
hemophore would be indicative of the presence of a gonococcal hemophore receptor.
This study thus presents a thorough examination of the roles of TdfG, TdfH and TdfJ in
gonococcal heme utilization.
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II. Results
A. TonB and TdT double mutants are not defective for growth in limited
heme conditions
Since the meningococcal TdfJ homologue, ZnuD exhibited some positive
indicators of a role in heme acquisition (see Table 4) we sought to evaluate the
contribution of TdfG and TdfH to growth in heme limited conditions in double mutants
unable to express TdfJ as well as TdfG or TdfH. Double mutants were made by first
generating a construct, pVCU938, in which the tdfJ gene fragment was inactivated by a
transposon encoding a Kan resistance cassette (Tn5<Kan-2>). This construct was then
used to transform gonococcal strains FA1090 tdfG (MCV660) and FA1090 tdfH
(MCV661) [83]. A schematic of the approach to mutant construction is presented Figure
3. Kanamycin resistant (Kanr) gonococci were colony purified and subjected to a PCR
screen for confirmation of the chromosomal mutation. In Figure 4, the genes tdfG, tdfH
and tdfJ were PCR amplified with gene specific primers from DNA preparations of Kanr
gonococcal transformants. The presence of a larger PCR product corresponding to the
size of the insertion in gonococcal transformants compared to wild type is shown in
Figure 4, confirming the successful generation of the tdfG tdfJ and tdfH tdfJ double
mutants designated MCV935 and MCV936, respectively.
To determine if TdfG, TdfH and TdfJ contribute to heme utilization, the growth of
wild type, tonB and TdT isogenic and double mutant strains were evaluated in a liquid
growth assay with limited heme as the sole iron source. We hypothesized that under
these conditions, TonB and TdT-dependent mechanisms of heme utilization
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Figure 3. Schematic of double mutant construction
Diagram of strategy for double mutant construction. (A) The plasmid, pVCU938, which
contains the gonococcal uptake sequence (GCU) as well as a fragment of tdfJ disrupted
by Tn5<Kan-2> used to transform MCV660 (tdfG) and MCV661 (tdfH) is depicted. (B)
Cartoon of homologous recombination event resulting in chromosomal integration of
mutagenized tdfJ to generate double mutants. Genetic elements are not drawn to scale.
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Figure 3. Schematic of double mutant construction
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Figure 4. PCR screen of TdT double mutants.
Boilate DNA preparations from Kanr MCV660 (tdfG) and MCV661 (tdfH) transformed
with pVCU938 were PCR amplified with primers specific for tdfG, tdfH and tdfJ. PCR
products were separated on a 1% agarose gel. (A) PCR screen of MCV935, tdfG tdfJ
double mutant. Gene targets are listed above. Template DNA from the following strains
were used for PCR: lane 1—wild type, FA1090; lane 2—MCV660 (tdfG); lane 3—
MCV661 (tdfH); lane 4—Kanr MCV660 clone; lane 5—No template DNA. (B) PCR
screen of MCV936, tdfH tdfJ double mutant. Template DNA from the following strains
were used for PCR: lane 1—MCV660 (tdfG); lane 2—MCV661 (tdfH); lane 3—Kanr
MCV661 clone 1;lane 4—Kanr MCV661 clone 2; lane 5—No template DNA.
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Figure 4. PCR screen of TdT double mutants.
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would be observed by a growth defect in mutants lacking putative heme receptors.
Gonococci were grown in partially chelexed GW media, a defined media permitting
growth of gonococci from low inocula [251], in the presence of limited amounts of hemin
and Desferal to chelate excess iron. Bacterial growth was measured via optical density
(OD) readings every 2 hours for 8 hours, the results of which are presented in Figure 5.
We found that tonB and TdT isogenic and double mutants were not defective for growth
in heme limited conditions compared to wild-type strain FA1090 (Figure 5A). In fact, the
tdfG isogenic and tdfG tdfJ double mutants grew significantly better than all of the
strains tested. To ensure that optical density readings adequately represented any
observable differences in growth, viable bacteria recovered from wild type and tonB
after heme limited growth were enumerated. There was no significant difference in the
amount of viable bacteria recovered indicating that TonB and the aforementioned TdTs
do not contribute to gonococcal growth in these conditions (Figure 5B).
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Figure 5. Heme-limited growth of tonB and TdT isogenic and double mutants.
Gonococcal strains were grown in partially chelexed GW media supplemented with
limited amounts of heme, 5µM. (A) Bacterial growth was measured via OD600 readings
every 2 hours for 8 hours. Means and standard error of n=5 independent experiments
are shown. (B) Viable bacteria recovered from wild type and tonB gonococci after
growth for 8 hours in limited heme conditions were enumerated. Mean and standard
error for n=4 independent experiments are shown. An un-paired Student’s t-test was
used to determine significant differences in means; nd, no difference.
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Figure 5. Heme-limited growth of tonB and TdT isogenic and double mutants.
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B. Heme utilization in gonococcal heme auxotroph is TonB-independent
Many bacterial pathogens that express heme receptors have incomplete heme
biosynthetic pathways and are thus natural heme auxotrophs. As such, these
pathogens require uptake of exogenous heme to support growth. N. gonorrhoeae has a
complete heme biosynthetic pathway and does not require heme if it is provided
exogenously along with an alternate iron source. It is possible that in the conditions of
the previous assay, the gonococcal strains tested were not restricted to uptake of
exogenous heme. To optimize the heme-dependent growth assay conditions and better
resolve any TonB and/ or TdT-dependent heme utilization mechanisms, we generated a
N. gonorrhoeae heme auxotroph as well as tonB and TdT mutants in this background
and evaluated heme-dependent growth. We hypothesized that growth of the gonococcal
heme auxotroph in limited heme conditions would require energy dependent uptake of
exogenous heme and thus require TonB and a heme receptor.
To generate gonococcal heme auxotrophs, we obtained pUNCH1304, a
construct in which gonococcal hemH is disrupted by a chloramphenicol
acetyltransferase cassette, CAT [237]. The enzyme ferrochelatase, encoded by hemH,
catalyzes the addition of iron to protoporphyrin IX to form protoheme. The hemH::CAT
construct was then used to transform wild type, tonB, and TdT isogenic and double
mutants. Chloramphenicol resistant (Cmr) gonococci were screened for chromosomal
hemH mutation via PCR amplification with gene specific primers. As shown in Figure 6,
a wild-type copy of hemH results in a PCR product of 1.3Kb. The mutant copy or
insertionally inactivated hemH was detected in transformed gonococci as indicated by
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PCR products of 2.3Kb, corresponding to the 1Kb CAT (Lanes 2, 7, 9-12). Table 5 lists
all of the heme auxotrophic mutants generated.
The growth of wild type, hemH, and tonB hemH were evaluated in a liquid growth
assay with limited heme. While both hemH and tonB hemH strains grew less well than
wild type, there was no difference in growth observed between hemH and tonB hemH
(Figure 7). These data indicate that TonB is not required for gonococcal growth
restricted to exogenous heme uptake. Since heme uptake and subsequent growth was
found to be TonB-independent in the gonococcal heme auxotrophic background, the
remaining TdT hemH mutant strains were not further evaluated.
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Figure 6. PCR screen of N. gonorrhoeae hemH mutants.
Boilate DNA preparations from Cmr FA1090 (wild type) and MCV656 (tonB) gonococci
transformed with pUNCH1304 (hemH::CAT) were PCR amplified with hemH specific
primers. PCR products were separated on a 1% agarose gel. Lanes 1 and 6 contain
DNA ladder. Lanes 2 and 3 are clones from Cmr FA1090. Lane 4 is a positive control
with wild type template DNA. Lane 5 is a negative control with no template DNA. Lanes
7-12 are clones from Cmr MCV656.
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Figure 6. PCR screen of N. gonorrhoeae hemH mutants.
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Table 5. N. gonorrhoeae heme auxotrophic mutants

Strain

Genotype

PCR
confirmation

MCV937

tdfGΩ, tdfJ::Tn5, hemH::cat

+

MCV939

tdfJΩ, hemH::cat

+

MCV943

tdfGΩ, hemH::cat

+

MCV944

hemH::cat

+

MCV945

tdfHΩ, hemH::cat

+

MCV946

tonBΩ, hemH::cat

+

MCV947

∆tbp, hemH::cat

+
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Figure 7. Heme-dependent growth of N. gonorrhoeae wild type and heme
auxotrophic strains.
Wild-type strain FA1090, hemH, and tonB hemH were grown in CDM supplemented
with 5µM heme. Bacterial growth was measured via OD readings every 2 hours for 6
hours. Means and standard error of a representative of n=3 independent experiments is
shown. Differences in means at T=6 hours were determined by a Bonferroni Post-test in
GraphPad Prism. P-values < 0.05 were considered significant and denoted with **.
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Figure 7. Heme-dependent growth of N. gonorrhoeae wild type and heme
auxotrophic strains.
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C. N. gonorrhoeae cannot utilize P. gingivalis hemophore, HusA as a
sole iron source
The data reported thus far demonstrate that neither TonB nor TdfG, TdfH and
TdfJ contribute to growth under limited heme conditions indicating that these TdTs are
not free heme receptors. The possibility remains however that these TdTs may not
function in uptake of free heme but rather assimilate heme from a heme-containing
protein. N. gonorrhoeae has only been demonstrated to assimilate iron and heme from
the host hemoprotein, Hg. It cannot utilize heme-Hx, serum albumin, myoglobin, or
catalase as has been shown for other pathogenic bacteria [27, 65, 237]. However,
another hemoprotein may be present within the context of infection: bacterial derived
hemophores. The urogenital tract, the primary site of gonococcal infection, is rich in
both normal and potentially harmful bacteria, which may produce proteins and
metabolites facilitating iron/heme acquisition. Despite being unable to produce a
siderophore [259], N. gonorrhoeae is capable of utilizing siderophores secreted by other
bacteria [36, 98]. Similarly, N. gonorrhoeae may be able to utilize hemophores
potentially secreted by bacteria within the same ecological niche.
To identify potential candidate hemophores, we conducting a literature review to
identify BV-associated bacteria with iron acquisition systems that N. gonorrhoeae could
potentially hijack. Table 6 lists reported iron acquisition systems in BV-associated
bacteria. Of the BV-associated bacteria considered, recent genome sequences
revealed that Fusobacterium spp., Prevotella spp., and Porphyromonas gingivalis
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Table 6. Iron acquisition and hemolytic genes in BV-associated bacteria
BV-associated
bacteria

Normal
site of
infection

G. vaginalis

P. intermedia 17
P. bivia

TonBdependent
transporters
(TdT)

Ref.

siderophore
biosynthesis
genes

NR

[271]

Siderophore/
hemophore

Vaginolysin,
UGT

Fusobacterium spp.

Cytotoxin/
hemolysin

1 putative
hemolysin

ORAL/
UGT

NR

NR

5 putative TdTs

[116]

ORAL

Several
hemolysins

NR

8 putative heme
TdTs

[201, 275]

UGT

NR

NR

NR

[104]

P. gingivalis

Sneathia amnii

3 heme
receptors

ORAL/
UGT

several
gingipains

HusA

UGT

2 putative
hemolysins

NR

[77, 137]
5 additional
putative TdT

UGT, urogenital tract; ORAL, oral cavity; NR, not reported
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NR

[93]

encode genes annotated as TonB-dependent transporters with putative or described
functions in heme uptake [116, 170, 201]. Proteomic analysis of the outer membrane of
Prevotella intermedia 17 also revealed the expression of TonB-dependent transporters
involved in heme uptake in iron limited conditions [275]. Interestingly, the hmu locus of
P. gingivalis encoding the bipartite heme receptors HmuR/Y was also found in
Prevotella intermedia 17. P. gingivalis and Prevotella spp. are within the Bacteroidetes
phylum. A hemophore-like protein, HusA from P. gingivalis was recently identified [77].
This 21kDa protein was found to be both extracellular and cell-surface associated,
demonstrated high affinity heme binding, and was required for heme utilization [77].
Given the relatedness of P. gingivalis and Prevotella spp., their expression of some
homologous heme utilization systems, and their potential role in BV [180, 194, 275], the
hemophore HusA was tested for its ability to support gonococcal growth as a sole
iron/heme source.
Recombinant HusA was expressed and purified from E.coli BL21 strain
expressing pETR7, a pET24d (+) derivative expressing HusA minus the first 23 amino
acid residues of a putative signal peptide sequence followed by a C-terminal His6-tag
[77]. The purified recombinant protein at approx. 21kDa is shown in elution samples in
Figure 8. To test the ability of HusA to support gonococcal growth, wild type, tonB,
hemH, and tonB hemH strains were spread onto CDM plates supplemented with
Desferal to chelate contaminating iron. Various iron sources were then added to wells
bored into the solidified media. HusA, saturated with 50% heme, was one of the iron
sources tested to support gonococcal growth. Control iron sources included apo bovine
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Figure 8. Purified recombinant P. gingivalis hemophore, HusA.
Samples collected during purification of recombinant P. gingivalis hemophore, HusA
were separated on a 15% SDS-PAGE gel and Coomassie stained. Lanes are labeled
as follows: M, molecular weight marker; FT, flow through; W1-2, wash samples; E1-5,
elution samples; R, final rinse.
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Figure 8. Purified recombinant P. gingivalis hemophore, HusA.
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E5

R

transferrin (apo-bTf), 30% saturated human transferrin (hTf), and free hemin. Plates
were incubated overnight at 37°C with 5% CO2 and growth around each iron source
was recorded. The growth of wild-type strain FA1090 around various iron sources is
shown in Figure 9. As expected, apo-bTf did not support growth of wild type while 30%
sat. hTf and free hemin in the presence or absence of excess Desferal all supported
growth. HusA; however, at 50% heme saturation, was not able to supplement growth of
wild-type N. gonorrhoeae or any of the strains tested. The growth phenotypes of tonB,
hemH, and tonB hemH strains are listed in Table 7. As expected tonB did not grow
when supplemented with apo-bTf or 30% saturated (sat.) hTf as utilization of hTf
requires energy derived from TonB. The tonB mutant was still capable of heme
utilization consistent with our findings and previous reports that gonococcal heme
utilization is TonB-independent [19]. Also, the hemH and tonB hemH strains behaved as
expected in that neither strain grew without heme supplementation despite the presence
of an alternative iron source.
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Figure 9. Growth of N. gonorrhoeae wild-type strain FA1090 with hemophore
HusA and various iron sources.
Gonococcal strains were spread onto CDM agarose plates supplemented with 10µM
Desferal. Wells were bored into the solidified media and 20µL aliquots of various iron
sources were placed into each well before incubation at 37°C with 5% CO 2 overnight.
Growth of wild-type strain, FA1090 is pictured. Iron sources, labeled 1-7 counterclockwise, are as follows: 1—7.5µM apo-bTf; 2—7.5µM 30% sat. hTf; 3—10µM hemin;
4—10µM 50% sat. HusA; 5—10µM hemin + 10µM Desferal; 6—7.5µM 30% sat. hTf +
10µM Desferal; 7—7.5µM 30% sat. hTf + 10µM hemin + 10µM Desferal.
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Figure 9. Growth of N. gonorrhoeae wild-type strain FA1090 with hemophore
HusA and various iron sources.
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Table 7. Growth of N. gonorrhoeae strains with hemophore HusA and various iron
sources

10µM
Heme

50%
sat.
HusA

10µM
Heme
+ DFO

30%
sat. hTf
+ DFO

30% sat.
hTf + 10µM
Heme +
DFO

++

+

-

+

++

++

-

-

+

-

+

-

-

MCV944 hemH

-

-

+

-

+

-

+

MCV946 tonB hemH

-

-

+

-

+

-

+

apobTf

30%
sat.
hTf

FA1090, wild type

-

MCV656, tonB

Strain

DFO, Desferal; +, growth; ++, robust growth; - , no growth; sat., saturated
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III. Discussion
Neisseria gonorrhoeae is quite adept at utilizing host derived proteins to entirely
suffice for its nutritional requirement for iron. As such it encodes several TonBdependent receptors, four of which have been characterized to facilitate iron
assimilation from host proteins Tf, Lf and Hg as well as bacteria derived siderophores
[198]. In this study, we evaluated three uncharacterized gonococcal TdTs (TdfG, TdfH
and TdfJ) for their role in heme utilization. While some evidence of their potential
contribution to heme utilization has been reported (see Table 4), we re-examined them
as candidate heme receptors by focusing on three aims not yet considered in the body
of literature reported.
First, we examined the possibility of redundant heme receptors and constructed
double mutants unable to express TdfJ and TdfG or TdfH. When tonB as well as TdT
isogenic and double TdT mutants where grown in limited heme conditions we found that
neither TonB nor the TdTs alone or in combination contributed to growth (see Figure 5).
We next considered the possibility that our system was not stringent enough to require
gonococcal heme uptake and constructed gonococcal heme auxotrophs to require that
growth was restricted to uptake of exogenous heme. While we expected heme uptake
and growth of gonococcal heme auxotrophs in limited heme conditions to require
energy, we found that TonB and by definition TdTs were not required (see Figure 7).
These data lead us to conclude that under limited heme conditions, N. gonorrhoeae
utilization of free heme occurs independently of TonB.
It is possible that there are un-identified TonB systems which support gonococcal
heme utilization despite lack of obvious gonococcal tonB paralogs in genome
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annotations. Most bacteria with multiple TdTs for the uptake of various nutrients in
different conditions encode more than one tonB paralog (anywhere from 2-9 have been
reported) with partial redundancy and distinct specificity [48]. S. marcescens, for
example, encodes six tonB paralogs [178]. HasB, a tonB paralog is encoded by the has
operon and provides energy to the TdT HasR, to internalize free heme or heme from
hemoproteins. Either TonB or HasB of S. marcescens can energize HasR, but HasB
does so more efficiently [178]. Additionally, the structural diversity of tonB paralogs and
limited sequence similarity may further obscure the presence of non-obvious tonB
paralogs [59]. However, the observation that disruption of the one known TonB system
is sufficient to abrogate transferrin, lactoferrin, and hemoglobin utilization [224] suggests
that N. gonorrhoeae probably encodes a single TonB system, which is sufficient to
support the function of all gonococcal TdTs.
TonB-independent mechanisms of heme utilization have been dismissed as
irrelevant because of the assumption that in the absence of energy, passive diffusion of
nutrients across the outer membrane would require high heme concentrations, a
scenario rare to mucosal environments where pathogenic Neisseria cause infection
[209]. Our data suggest that even in very limited heme conditions, heme uptake occurs
independently of TonB indicating that TonB-independent heme utilization may be
physiologically relevant. As such, mechanisms of TonB-independent heme utilization
may be of interest. Chen et al., reported that spontaneous mutants in PilQ increased the
entry of heme, TX-100 and antibiotics as demonstrated by a hyper-sensitivity to heme
and hydrophobic agents [44]. The effects of the pilQ mutations were decreased by loss
of pilT, indicating that PilT helps to increase entry of small molecules through PilQ. PilQ
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forms an exit pore for the assembled pilus fibril and PilT is responsible for twitching
motility mediated by pilus retraction. Additionally, PilT is required for DNA transport into
the cell and facilitates pilus degradation in the absence of PilQ [265]. As such, Chen et
al., argued that entry of heme and hydrophobic agents may be mechanically linked to
pilus retraction [44]. PilQ however cannot be the only mechanism of TonB-independent
heme entry as strains lacking PilQ are still able to grow on free heme.
Porins have been suggested as a non-specific heme entry mechanism [209].
However, lipophilicity in solute molecules has been shown to retard diffusion through
the porin channel [174]. Additionally, heme tends to form hydrophobic aggregates which
may be too large to diffuse through porins [133]. Diffusion of heme across the outer
membrane may not require a protein channel, as the Neisseria outer membrane is
generally highly susceptible to lipophilic agents [174]. This may be due to modification
or masking of the phospholipid head groups as mutants with increased sensitivity to
hydrophobic agents also demonstrated increased sensitivity to phospholipase C
compared to wild type and mtr containing strains which were only sensitive to
phospholipase C upon treatment with exoglycosidase [152]. The structure of neisserial
LOS may also contribute to increased outer-membrane permeability to hydrophobic
agents. LPS with short or no O-side chains was found to have increased fluidity
compared to LPS with long O-side chains [174]. Additionally, faster lateral diffusion of
an outer membrane protein was found in mutants unable to make LPS O-chain [174].
Increased membrane permeability to lipophilic molecules due to short O-side chains
may also explain why heme uptake in Neisseria is TonB-independent, but TonBdependent and receptor mediated in other bacteria that would produce LPS with long O-
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side chains and thus potentially have membranes less permeable to lipophilic
molecules. In N. meningitidis, hyper-sensitivity to heme has been attributed to mutations
in ght, named gene of hydrophobic agent tolerance [192]. The ght gene product was
originally thought to be a periplasmic protein but recent studies have shown that Ght is
an N-terminally anchored inner membrane protein with a cytoplasmic domain that
interacts directly with LpxC to help regulate LPS biosynthesis [187]. Meningococcal
studies have shown that mutations in ght result in decreased production of LPS and
increased sensitivity to heme and other hydrophobic agents further supporting the role
of LPS structure in outer-membrane permeability and potentially non-specific heme
entry in Neisseria. Interestingly, attempts to construct ght mutant in N. gonorrhoeae
have failed suggesting that ght is an essential gene in the gonococcus [192]
Our studies also examined the possibility that the TdTs, TdfG TdfH and TdfJ
were not receptors for free heme, but rather other hemoproteins. Besides Hg and HgHp complexes, pathogenic Neisseria cannot utilize other host derived hemoproteins like
heme-Hx and heme-albumin as has been demonstrated for other heme receptors [65,
209, 254]. The utilization of a bacterial derived hemophore is not inconsistent with
Neisseria biology, as N. gonorrhoeae has been shown to be capable of utilizing
siderophores synthesized by other bacteria [36, 98, 227]. As far as we are aware, this is
the first study to examine the ability of N. gonorrhoeae to utilize a bacterial hemophore.
We found that hemophore-like protein, HusA from P. gingivalis was not able to support
gonococcal growth as the sole iron/heme source suggesting that N. gonorrhoeae does
not encode a hemophore receptor for this protein. We hypothesized that HusA would be
the best candidate hemophore to test since it may likely be encountered by N.
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gonorrhoeae given its expression by P. gingivalis and the association of
Porphyromonas and Prevotella species with BV, a known risk factor for gonococcal
infection [263]. However, the hemophores described in the literature thus far (HusA,
HasA-type, and HxuA) have no sequence similarity and demonstrate different
mechanisms of heme coordination, and so it is also possible that Neisseria gonorrhoeae
may be able to utilize another type of hemophore. The ability of HasA and HxuA to
support gonococcal growth would need to be tested to conclusively state that N.
gonorrhoeae does not encode a hemophore receptor. Since HxuA does not actually
bind heme, but rather inactivates the biological function of Hx by inducing release of
heme upon interacting with Hx [253], a gonococcal receptor for utilization of HxuA or
HxuA-hemopexin is unlikely. The expression of the HasA-type hemophore in multiple
bacteria may indicate an increased likelihood to be a ligand of any putative receptormediated hemophore utilization in N. gonorrhoeae.
These studies and others reported in the literature have attempted to identify
additional TdTs contributing to heme utilization in Neisseria gonorrhoeae, but the lack of
identification of novel specific mediators of gonococcal heme utilization despite reported
and unreported efforts, may indicate that the currently described mechanisms of heme
utilization represent the sum total of specific receptor-mediated strategies. Additionally,
the collection of mutants in either pilQ, mtrCDE or ght demonstrating phenotypes of
hyper-sensitivity further support findings that heme entry in Neisseria is non-specific [26,
44, 192]. By demonstrating that in low heme conditions gonococcal heme utilization
occurs independently of TonB even when exogenous heme uptake is required for
growth and that N. gonorrhoeae cannot assimilate heme from a candidate hemophore,
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our findings support the conclusion that heme utilization in Neisseria gonorrhoeae is
non-specific and independent of TonB and TdTs.
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Chapter 4: Regulation of gonococcal TdTs: TdfG TdfH and TdfJ

I. Introduction
In order to readily adapt to changing environments, bacteria regulate expression
of genes that optimize growth in specific nutritional conditions. TonB-dependent
transporters, as mediators of active uptake of essential nutrients that are either poorly
permeable though porins or present at low concentrations, are highly regulated to
optimize their expression in conditions where they are required. Regulation of the TdTs
described thus far occurs at the transcriptional and post-transcriptional level through the
activity of transcriptional regulators, riboswitches, and regulatory small RNAs (sRNAs)
[175].
All TdTs that function in the transport of iron or iron-chelates are regulated by the
transcriptional regulator, Fur. Fur, for ferric uptake regulator, generally acts as a
repressor. In the presence of high intracellular levels of Fe2+, the Fur homodimer binds
co-repressor Fe2+ and the holo-protein binds to a DNA sequence motif called the Fur
box in the promoter of regulated genes thereby repressing their transcription. In low
cellular Fe2+ levels, apo-Fur does not bind the Fur box, resulting in de-repression of
regulated genes. Other transcriptional regulators within the Fur family of
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metalloregulatory proteins have also been shown to repress TonB-dependent
transporters; for example NikR, for which Ni2+ acts as a co-repressor, represses the Ni
transporter FrpB4 in Helicobacter pylori [205]. Additionally, Fur can indirectly regulate
iron transport genes by regulating other types of regulators including two-component
regulatory systems (TCS), AraC-like activators, and extra cytoplasmic function (ECF)
sigma factors [87].
A sub-class of TonB-dependent transporters, termed transducers, function as
both transporters and signal transducers that facilitate transcriptional activation of genes
involved in transport of the TdT ligand. In addition to the plug and β-barrel domains of
TonB-dependent transporters, these transducers are characterized by the presence of a
unique N-terminal extension that functions as the signaling domain [122]. Perhaps the
best characterized of these transducers is FecA, the TonB-dependent receptor for ferric
citrate in E. coli K12. Signal transduction requires additional components; FecR, an
inner membrane protein that functions as an anti-σ factor and FecI, an ECF σ factor that
recruits RNA polymerase upon DNA binding to activate transcription [31]. Upon binding
of the cognate ligand, ferric citrate, to the receptor FecA, conformational changes in
FecA promote interaction of the N-terminal signaling domain of FecA with the
periplasmic C-terminal end of FecR. The signal is transduced through the
transmembrane segment of FecR to the N-terminal cytoplasmic end that activates FecI.
FecI in turn binds to the promoter of the fecABCD operon and recruits RNA polymerase
to induce transcription [29]. The FecI/R genes and the fecABCD operon are also
Fe2+/Fur repressed so the fecABCD operon is doubly controlled guaranteeing rapid
response to the cell’s iron status [31]. TonB-dependent transducers represent the
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minority of TonB-dependent receptors; however, FecI/R type regulation has been
identified in the homologous Fec systems of Klebsiella pneumoniae, Aerobacter
aerogenes, and Shigella flexneri as well as heme and hemophore acquisition systems
in Bordetella spp. and Serratia marcescens, respectively [30]. While the genomes of
pseudomonads and Bacteriodes spp. are highly representative of transducer-type TdTs,
genera of several important human pathogens including Hemophilus, Salmonella, and
Neisseria seem to encode none [122].
At the post transcriptional level some TdTs are regulated by riboswitches, RNA
elements located at the 5’ end of mRNAs that change conformation upon ligand binding
and modulate transcription or translation of the downstream gene(s) [175]. Expression
of BtuB, the TdT for vitamin B12 (cobalamin) is controlled by a riboswitch at the 5’ end of
the btuB mRNA. Vitamin B12 and adenosylcobalamin, a downstream product of vitamin
B12 metabolism, bind to the riboswitch and induce the conformational change
responsible for btuB repression [175]. The cobalamin and thiamine pyrophosphate
responsive riboswitches may also regulate putative Co2+ and thiamine transport TdTs in
addition to the vitamin B12 receptor [206].
The small regulatory RNAs, OmrA and OmrB have also been shown to
negatively regulate expression of TonB-dependent transporters: CirA, FecA, and FepA,
the colicin I, ferric citrate, and ferric enterochelin receptors, respectively. The sRNAs,
OmrA/B bind to the RNA chaperone, Hfq, which promotes RNA-RNA interactions [175].
OmrA/B are thought to repress CirA, FecA and FepA by directly base-pairing to early
translation regions of the TdT mRNAs, this sRNA/mRNA binding inhibits translation and
leads to subsequent degradation of the RNA complex [175]. OmrA/B are themselves
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regulated by the TCS EnvZ/OmpR, osmolarity regulators further demonstrating a
relationship between environmental conditions and TdT expression. OmrA/B are
present in some other enterobacteria such as Salmonella, Klebsiella, and Yersinia spp.
and while the regions of OmrA/B base pairing are conserved in cirA, the regulation of
CirA or FecA and FepA by OmrA/B has not yet been demonstrated in the latter species
[175].
In pathogenic Neisseria, the TdTs that facilitate iron/iron-chelate utilization from
transferrin (TbpA), lactoferrin (LbpA), hemoglobin/haptoglobin (HmbR and HpuB), and
foreign siderophores (FetA) are all repressed by Fe/Fur [64, 106, 183]. Additionally, the
TonB system and the fbpABC system, which transports ferric iron across the
cytoplasmic membrane, are all Fe/Fur repressed. Neisseria spp. do not encode any
TonB-dependent transducers and so do not display regulation by ECF σ-factors [122].
Recently, our laboratory reported that the bi-cistronic operon encoding the transferrin
binding proteins TbpB and TbpA were found to be regulated by a long non-coding RNA
located in the un-translated region upstream of tbpB [249]. In contrast to the described
sRNAs, this RNA species is large at approximately 1.8Kb, does not overlap with the 5’
end of target gene tbpB and demonstrates limited regions of sequence complementarity
[249]. This is the only instance of a putative regulatory RNA to regulate a neisserial TdT
and so may represent a novel mechanism of TdT regulation in Neisseria; however,
activity on other gonococcal genes and expression of this RNA species in N.
meningitidis remains to be determined. In addition to Fur some neisserial TdTs have
also been identified as targets in regulons of the two-component regulatory system
(TCS) MisR/S and the AraC-like regulator, MpeR as well as the Fur family regulator
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PerR/Zur. As such the reported activity of these transcriptional regulators in pathogenic
Neisseria spp. is summarized below.
The TCS, MisR/S is also referred to as PhoP/Q due to its homology to the
PhoP/Q system of Salmonella and other enteric bacteria that regulate expression of
virulence genes in response to Mg levels and pH [111]. Inactivation of PhoP/Q in other
bacteria results in dramatic attenuation of virulence [164, 232]. Like other described
TCS, MisR/S is comprised of a sensory histidine kinase, MisR, which is an inner
membrane protein with periplasmic and cytosolic domains and response regulator,
MisR, which is localized to the cytoplasm. Upon activation by an environmental
stimulus, MisS undergoes auto-phosphorylation. MisS interacts with MisR via its
cytoplasmic domain and activates MisR by transferring the phosphoryl group to MisR.
The phosphorylation state of MisR modulates its DNA binding affinity resulting in
differential regulation of target genes, which includes the misR/S operon itself
demonstrating auto-induction [241]. Mutations of misR/phoP in N. meningitidis results in
a variety of phenotypes including strain dependent sensitivity to Mg levels [111, 239]
increased sensitivity to antimicrobial peptides and environmental conditions [111, 171172] as well as loss of PEA decorations from the inner core structure of LOS leading to
the designation of MisR for meningococcal inner core structure [239]. Mutation of
misR/phoP also resulted in increased sensitivity to mouse serum and reduced ability
transverse a human epithelial cell monolayer [111] and attenuated virulence in the
mouse model of infection indicating the role of this regulator in meningococcal virulence
[171]. More recently, the MisR/S was found to be induced in contact with host cells and
modulate genes involved in the adaptation of the bacterium to host cells suggesting that
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the inducing signal for the system is host cell derived [107]. Two MisR/PhoP regulons
have been described in N. meningitidis with approximately 30% overlap in regulated
genes possibly due to difference in strains and growth conditions used [172, 240]. Both
regulons identified TonB-dependent receptor TdfH as targets and TdfJ and HmbR were
also each identified by one of the two studies [172, 240]. These data suggest that the
MisR/S TCS may regulate some neisserial TdTs.
The transcriptional regulator MpeR is an AraC-like regulator expressed
specifically in pathogenic compared to be commensal Neisseria suggesting a potential
role in virulence [155, 214]. More than 10,000 AraC homologs have been identified in
protein databases throughout Gram-positive and Gram-negative bacteria thus
representing one of the largest families of bacterial regulatory proteins [269]. Generally,
AraC-like regulators have a conserved C-terminal DNA-binding domain and a variable
N-terminal domain that is responsible for both protein dimerization and ligand binding.
The paradigm for AraC-like regulators is the “light-switch” model of activation, wherein
the dimeric regulator binds to distal operator sites of target genes resulting in DNAlooping and repression of gene expression. Upon binding of the inducing ligand, the
regulator undergoes allosteric change resulting in binding to proximal sites in the
promoter of target genes resulting in opening of the DNA loop and transcriptional
activation [269]. In Neisseria, MpeR is one of three AraC-like regulators [67]. MpeR is
repressed by Fe/Fur and so can also act as a secondary regulator for indirect Fur
activity [61, 64, 106]. The TdT, TdfF, which was found to be important for intracellular
survival [83], is oriented in the opposite direction within the same genetic locus
encoding MpeR. Thus, MpeR is hypothesized to regulate expression of TdfF [51],
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although this has not been directly demonstrated. MpeR was however found to bind to
the promoter of a putative iron related periplasmic binding protein (PBP) located
upstream and in the same orientation of TdfF; thus its promoter is thought to drive the
activity of the tdfF containing operon [67]. MpeR was also demonstrated to repress
expression of MtrF, an inner membrane protein that enhances mtrCDE mediated
induction of resistance to hydrophobic agents [71]. Additionally, MpeR was shown to
activate FetA, the TdT that mediates utilization of catechol-like siderophores [36, 98].
Microarray studies of the MpeR regulon in N. gonorrhoeae revealed that TdfH was
repressed late in the growth phase of mpeR mutant suggesting that TdfH is an MpeR
target [161].
The Fur family transcriptional regulator, PerR was originally identified in N.
gonorrhoeae as a peroxide sensing, Mn-dependent repressor that negatively regulates
MntC, the PBP of the Mn-binding ABC transporter encoded by mntABC responsible for
Mn-dependent resistance to oxidative stress [236, 268]. MntABC was later found to bind
both Mn and Zn with equal affinity and PerR was concluded to behave like Zur,
repressing target genes when bound to co-repressor Zn2+ in the presence of high
intracellular Zn levels analogous to the Fe/Fur repression [135, 143]. Microarray studies
of the PerR/Zur regulon in N. gonorrhoeae and the zinc responsive regulon of N.
meningitidis share significant overlap identifying genes involved in Zn transport and
maintenance of Zn homeostasis [181, 268]. Both regulons identified the TdTs TdfH and
TdfJ as Zn/Zur targets [181, 268]. Interestingly, a gonococcal perR mutant
demonstrated reduced invasion and intracellular survival in primary cervical epithelial
cells [268] indicating that this regulator contributes to host cell interactions.
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In the absence of described regulatory mechanisms beyond Fe/Fur described for
neisserial TdTs, the transcriptional regulators MisR and MpeR represent the only other
known modulators of TdT expression. Therefore, we sought to determine whether Fur,
MisR and MpeR regulate the uncharacterized TdTs: TdfG, TdfH and TdfJ in N.
gonorrhoeae. The identification of the regulatory networks to which these TdTs belong
may reveal pertinent information about their function and contributions to the
pathogenesis and fitness of N. gonorrhoeae in which little to no regulatory data on these
TdTs has been reported. In addition to the aforementioned transcriptional regulators, we
also assessed the expression of these TdTs in response to Zn and the Fur family Zn
regulator, PerR/Zur. Together these studies present a comprehensive analysis of
potential regulators of N. gonorrhoeae TdTs: TdfH TdfJ and TdfJ.
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II. Results
A. TdfG and TdfJ are Fur regulated
To determine whether TdfG and TdfJ were regulated by Fur, we evaluated the
expression of the gonococcal TdTs TdfG and TdfJ in a fur mutant. Wild type and fur
mutant strains were grown in GC broth in the presence of Fe3+-specific chelator,
Desferal to represent iron depleted conditions or in the presence of Fe(NO 3)3 to
represent iron replete conditions. Whole cell lysates standardized by culture density
were analyzed via Western blot analysis with specific antiserum to detect TdfG and
TdfJ. We found that TdfG expression was repressed in the presence of iron but
elevated in iron depleted conditions in the wild type (Figure 10A) as has been previously
reported [238]. There was no significant difference in TdfG levels detected in iron
replete versus iron-depleted conditions in the fur mutant strain due to de-repression of
TdfG in iron replete conditions (Figure 10A). These results indicate that the TdfG ironrepression is Fur-mediated. Interestingly, there was still a trend of increased TdfG
expression in iron depleted conditions in the fur mutant suggesting that other factors
may contribute to TdfG expression in the absence of Fur. Overall TdfJ expression was
reduced in the fur mutant compared to wild type. This difference was significant in iron
depleted conditions indicating that Fur contributes to TdfJ activation in low iron
conditions (Figure 10B). TdfJ expression is reported to be iron induced [64, 273];
however, densitometry analysis did not find significant differences in TdfJ levels
detected in iron replete versus depleted conditions in either wild type or the fur mutant
(Figure 10B).
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Figure 10. Fur regulation of TdfG and TdfJ.
Wild-type, FA1090 and fur mutant strains were grown for 2 hours in GC broth media
treated with Desferal or Fe(NO3)3 to represent iron depleted or iron replete conditions,
respectively. Whole cell lysates were standardized by culture density and analyzed via
Western blot analysis. Densitometry was performed on a single immunoblot with three
sets of replicate samples to determine arbitrary units (AU) of protein levels using NIH
ImageJ. An un-paired Student’s t-test was used to compare means of protein levels
detected. P-value < 0.05 was considered significant and denoted with *. (A) Left, a
representative immunoblot probed for TdfG is shown. Right, densitometry results of
TdfG levels detected (B) Left, a representative immunoblot probed for TdfJ is shown.
Right, densitometry results of TdfJ levels detected.
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B. TdfG is misR activated
We next assessed the expression of TdfG, TdfH and TdfJ in wild-type strain
FA1090 and the misR mutant to determine if MisR regulated any of these TdTs.
Western blots of whole cell lysates from wild type and misR strains grown in iron replete
and depleted conditions probed for each TdT are shown in Figure 11. Contrary to
microarray studies identifying TdfH and TdfJ as MisR targets in N. meningitidis [172,
240], we found that expression profiles of neither TdfH nor TdfJ were modulated in misR
mutant strains compared to wild type (Figure 11A). Surprisingly, we found that TdfG
levels were significantly reduced in the misR mutant in iron depleted conditions (P-value
= 0.0130) suggesting that MisR activates TdfG expression (Figure 11B). Additionally,
there was no difference in TdfG levels in the misR mutant grown in iron replete versus
depleted conditions further indicating that MisR activation contributes to the iron
regulation of TdfG (Figure 11B).
C. MpeR does not regulate TdfG, TdfH or TdfJ
TdfH was predicted to be an MpeR target in a gonococcal microarray study [161].
To determine if MpeR contributes to regulation of TdfH or any other TdTs, whole cell
lysates from wild-type FA1090 and the mpeR mutant grown in iron replete and depleted
conditions and analyzed via Western blot with specific antiserum. In Figure 12, we
demonstrated that none of the TdTs had altered expression profiles in the mpeR mutant
compared to wild-type strain FA1090.
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Figure 11. MisR regulation of TdfG, TdfH and TdfJ.
Wild-type, FA1090 and misR mutant strains were grown for 2 hours in GC broth media
treated with Desferal or Fe(NO3)3 to represent iron depleted or iron replete conditions,
respectively. Whole cell lysates were standardized by culture density and analyzed by
Western blot with antisera against TdfG, TdfH or TdfJ as indicated. Densitometry was
performed on a single immunoblot with three sets of replicate samples to determine
arbitrary units (AU) of protein levels using NIH ImageJ. An un-paired Student’s t-test
was used to compare means of protein levels detected. P-value < 0.05 was considered
significant and denoted with *. (A) Left, representative immunoblot probed for TdfH is
shown. Right, representative immunoblot probed for TdfJ is shown. (B) Top, a
representative immunoblot probed for TdfG is shown. Bottom, densitometry results of
TdfG levels detected.
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Fe

Figure 12. MpeR regulation of TdfG, TdfH and TdfJ.
Wild-type strain FA1090 and mpeR mutant were grown for 2 hours in GC broth media
treated with Desferal or Fe(NO3)3 to represent iron depleted or iron replete conditions,
respectively. Whole cell lysates were standardized by culture density and analyzed by
Western blot with antisera against TdfG, TdfH or TdfJ as indicated.
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D. TdfH and TdfJ are Zn repressed
We did not observe any changes in TdfH expression in response to iron as has
been previously reported [238]; thus, we sought to determine whether expression of
TdfH and TdfJ were responsive to Zn levels since they are predicted to be targets of the
Zn/Zur regulon in N. meningitidis and N. gonorrhoeae [181, 268]. Gonococcal wild-type
strain FA1090 was grown in CDM in the presence of the zinc specific chelator, TPEN,
ZnSO4 and/or Fe(NO3)3 at the indicated concentrations. We found that TdfH and TdfJ
levels were repressed in presence of Zn (Figure 13). Conversely, expression of both
proteins was up-regulated in the presence of increasing concentrations of TPEN. TdfH
expression levels did not change in response to iron; however, TdfJ expression was
further elevated when supplemented with iron, even at TPEN concentrations shown to
de-repress TdfJ expression (Figure 13) suggesting that TdfJ is iron-induced and zinc
repressed. To verify that TPEN treatment only altered Zn levels, we assessed
expression of transferrin binding protein B (TbpB), which is known to be iron regulated.
TbpB levels did not change at varying TPEN concentrations, indicating that TPEN
treatment in these conditions is Zn specific.
E. Zur mediates TdfH and TdfJ Zn repression
To assess whether the observed zinc repression of TdfH and TdfJ was Zurmediated, we generated zur isogenic mutants by transforming gonococcal strains FA19
and FA1090 with a zur::kan construct in which the zur gene is disrupted with a
kanamycin resistance cassette. Kanr gonococci were selected and screened for
chromosomal mutation via PCR with gene specific primers. In Figure 14 PCR products
from Kanr gonococci show an increase in size corresponding to the size of the
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Figure 13. Zn regulation of TdfH and TdfJ expression.
Whole cell lysates standardized by culture density were analyzed by Western blot with
antisera specific to TdfH, TdfJ or TbpB as indicated. Wild-type strain FA1090 was grown
for 4 hours in CDM supplemented with Fe(NO3)3, ZnSO4 or Zn specific chelator, TPEN
at the given concentrations.
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Figure 14. PCR screen of FA19 and FA1090 zur mutants.
Boilate DNA preparations from Kanr FA1090 and FA19 gonococci transformed with
zur::kan were PCR amplified with zur specific primers. PCR products were separated on
a 1% agarose gel. (A) Lane 1—DNA ladder, lane 2—wild type template, lane 3—no
DNA template, lanes 4-9—clones from Kanr FA19. Positive clones are denoted with an *
and were designated MCV963. (B) Lane 1—DNA ladder, lane 2—wild type template,
lane 3—no DNA template, lanes 4-10—clones from Kanr FA1090. Positive clones are
denoted with * and were designated MCV964.
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kanamycin cassette confirming mutation. Zur mutants in FA19 and FA1090 background
were designated MCV963 and MCV964, respectively. FA1090, FA19 and their
respective zur mutant derivatives were then grown in GCB treated with ZnSO4 or TPEN
to represent Zn replete or Zn depleted conditions, respectively and whole cell lysates
were analyzed by Western blot. We found that expression of both TdfH and TdfJ was
up-regulated under Zn depleted conditions in the wild type backgrounds and was
significantly increased in zur mutant derivatives in both backgrounds (Figure 15).
Additionally, TdfH and TdfJ were not differentially expressed under Zn replete versus Zn
depleted conditions in zur mutants (Figure 15). These data indicate that Zn repression
of TdfH and TdfJ is Zur mediated. We also observed that TdfH expression was
noticeably higher in strain FA1090 compared to FA19 regardless of Zn levels while TdfJ
expression was similar in both backgrounds (Figure 15). Interestingly, the increased
TdfH expression in FA1090 versus FA19 was observed in the respective zur mutants.
This suggests that the observed increase of TdfH expression in FA1090 occurs
independently of Zur.
F. TdfH is MisR activated in gonococcal strain FA19
In an attempt to identify factors contributing to decreased TdfH expression in strain
FA19, we re-examined the role of MisR in the FA19 background since the MisR
regulatory network is distinct in different gonococcal strains (William M. Shafer, personal
communication). We found that the misR mutant derivative in the FA1090 background
showed no difference in TdfH expression compared to its parent when grown in Zn
replete and Zn depleted conditions (Figure 16). By contrast, in FA19 the misR mutant
derivative expressed less TdfH compared to its parent in both Zn replete and depleted
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conditions (Figure 16). MisR was not found to alter the expression of TdfJ in either
FA1090 or FA19. These data indicate that TdfH expression is controlled by additional
players beyond Zn/Zur such as MisR, and that this regulatory pathway is distinct in
different gonococcal strains.
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Figure 15. Zur regulation of TdfH and TdfJ.
Parental strains FA1090 and FA19 and respective zur mutant derivatives were grown in
Zn replete and depleted conditions. Whole cell lysates standardized by culture density
were analyzed by Western blot with antisera to TdfH or TdfJ as indicated.
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Figure 16. TdfH is MisR regulated in gonococcal strain FA19.
Parental strains FA1090 and FA19 and respective misR mutant derivatives were grown
under Zn replete and depleted conditions. Whole cell lysates standardized by culture
density were analyzed by Western blot with antisera specific to TdfH or TdfJ as
indicated.
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III. Discussion
In this study we analyzed the expression of TdTs TdfG, TdfH and TdfJ in
response to Fe and Zn as well as transcriptional regulators Fur, MisR, MpeR and Zur.
Given the abundance and at times conflicting reports of the TdTs expression in N.
meningitidis and N. gonorrhoeae this study condenses the predicted regulators and
examines their contribution to TdT regulation in N. gonorrhoeae to provide a
comprehensive assessment of their expression and yield novel information about their
potential function.
Perhaps the least information is known about the gonococcal TdT, TdfG. It is the
largest TdT in the neisserial genome, with an apparent molecular weight of 130kDa.
Interestingly, it is absent in all meningococcal genomes as well as commensal Neisseria
with the exception of N. elongata, the most ancestral of the Neisseria species evaluated
in a comparative genomic study of commensal and pathogenic Neisseria [155]. This
indicates that TdfG may represent a product of niche adaptation and be of particular
importance for survival in the urogenital tract. TdfG was previously reported to be upregulated under conditions of iron limitation [64, 238] and the presence of a Fur box in
the TdfG promotor was confirmed by Fur Titration Assay [106]. As such, we were not
surprised to find that TdfG iron repression was Fur mediated. However, we were
surprised to observe that TdfG expression was also MisR regulated specifically in iron
limited conditions. MisR is not regulated by Fe/Fur indicating that the observed MisR
activation occurs independently of Fur. This is the first report of an additional regulator
modulating TdfG expression. Given the reported role of MisR/S in virulence and its
potential role as regulator mediating adaptation to host cells [107, 171], the apparent
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presence of TdfG in the MisR/S and Fur regulons may be indicative of a role in
facilitating the utilization of a host-derived iron chelate. TdfG however, was not found to
contribute to intracellular survival of N. gonorrhoeae in ME180 cervical epithelial cells
[83]. Nonetheless, this novel finding in regards to TdfG expression represents an
interesting development. Further studies to determine whether the observed MisR effect
occurs directly or indirectly should be pursued.
In stark contrast to TdfG, perhaps the most data, for an uncharacterized TdT has
been reported for TdfJ, which is found throughout human Neisseria spp. TdfJ was
reported to be up-regulated under iron replete conditions in N. gonorrhoeae [64, 273]. In
the absence of TdfJ specific antibodies, changes in protein expression were not
previously examined. However, our lab has found that TdfJ is indeed induced in the
presence of iron [176]. We also report here for the first time in the gonococcus that TdfJ
is Zn/Zur repressed. A Fur box was previously detected in the promoter of tdfJ
(NGO1205) in N. gonorrhoeae and a mechanism of direct Fur-mediated activation has
been proposed since iron induction of tdfJ transcript was not observed in a fur mutant
and Fur was found to specifically interact with the tdfJ promoter [273]. However, a Zur
box adjacent to and slightly overlapping the putative Fur box was also detected in the
promoter of meningococcal homologue znuD [126, 225]. Zur specifically co-factored to
Zn2+ was demonstrated to directly interact with the znuD promoter in N. meningitidis
[181]. In N. meningitidis, znuD promoter activity was up-regulated in the presence of
iron even in a zur mutant and Fur was also found to specifically interact with the znuD
promoter [126]. Additionally, in the presence of both zinc and iron znuD promoter
activity was repressed in wild type but induced in the zur mutant indicating that Zur

117

repression out competes the Fur-mediated activation when both Fur and Zur are
expressed [126]. Together these data lead to proposed model whereby Fur binding can
further augment ZnuD expression levels in zinc limiting conditions wherein znuD is
already de-repressed. However, in zinc replete conditions, Zn/Zur binds to the Zur box
and blocks Fe/Fur binding repressing znuD transcript and preventing Fur mediated
activation in the presence of iron [126]. Our findings that TdfJ is both Fur activated and
Zn/Zur repressed in the gonococcus support this model.
It remains unclear why TdfJ would be simultaneously iron induced and zinc
repressed. If TdfJ is in indeed a Zn transporter, it may be preferable to actively take in
more Zn in high iron conditions to protect against the potential toxicity of high
intracellular iron levels, although this would require simultaneously low Zn conditions to
de-repress tdfJ. We did not observe any changes in TdfJ expression in the misR
mutant, despite its identification as a MisR target in microarray studies [172] and its
reported contribution to adhesion, invasion, and survival in A549, human lung epithelial,
cells in N. meningitidis [126].
In addition to TdfJ, we also report that in N. gonorrhoeae, TdfH is Zn/Zur
repressed in support of microarray studies of zinc-responsive and Zur regulons in N.
meningitidis and N. gonorrhoeae, respectively [181, 268]. We also report that while
TdfH expression was unaffected by the presence of MisR in N. gonorrhoeae strain
FA1090, it was reduced in the misR mutant in gonococcal strain FA19 indicating that
TdfH is MisR activated in FA19 and differentially regulated in these two gonococcal
strains. The overall increase in TdfH expression in strain FA1090 versus FA19 that
remains evident in both zur and misR mutants suggest that other
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factor(s)/mechanism(s) independent of Zur and MisR also contribute to the difference in
TdfH levels detected between strains. This is the first study to report that TdfH
expression is distinct in different gonococcal strains and may also be controlled by
additional factors beyond transcriptional regulators Zur and MisR.
We did not detect any changes in the expression of any of the TdTs tested in an
mpeR mutant despite the report that tdfH transcript was reduced late in the log-growth
phase of an mpeR mutant [161]. We should note that the expression studies reported
here were conducted in the FA1090 background, while the MpeR regulon was reported
for gonococcal strain FA19. This may be of significance since we detected dramatic
changes in TdfH expression in the two backgrounds. As such, MpeR regulation should
also be assessed in FA19.
FA1090 and FA19 are both experimental strains of N. gonorrhoeae routinely
used in the laboratory. FA1090 was isolated from the cervix of an individual with DGI,
while FA19 was isolated from a patient with uncomplicated gonorrhea [113]. Distinct
regulatory mechanisms have been previously reported in FA19 and FA1090. For
example, MtrA, another AraC-like transcriptional activator that has been shown to
activate expression of the multiple transferable resistance efflux pump (mtrCDE), is fully
expressed in strain FA19 but contains an 11-bp deletion within the coding region in
strain FA1090. Thus, FA19 but not FA1090 can induce expression of the Mtr efflux
pump to induce resistance to hydrophobic agents [200]. In addition to activating
mtrCDE, MtrA also represses MpeR [242]. It is possible that the misR effect in
gonococcal strain FA19 reported here may be indirect as MisR/S, MpeR, and MtrA are
connected in a regulatory network [161, 242], although MisR was found to directly
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interact with the tdfH promoter in N. meningitidis [240]. Further investigation of the direct
or indirect role of these regulators on TdfH expression will help to identify the novel
players and/or the mechanism of any strain specific regulation.
In previous studies, TdfH expression was detected in all meningococcal strains
tested [226, 238] and 81% of gonococcal strains [238]. Of note, TdfH expression was
not detected in any species of commensal Neisseria except for one out of six Neisseria
lactamica strains [238] despite the presence of the gene in some commensal species
[155]. In their comparison of genome sequences among human neisserial species,
Marri et al. note that Neisseria lactamica has the most virulence associated alleles of all
the commensals and can occasionally cause infection [155]. As previously noted, TdfH
expression may be regulated by transcriptional regulator MpeR, which is found on a
genetic locus specific to pathogenic Neisseria [155, 214]. It is possible that despite the
presence of tdfH in select commensal species, its expression may be limited to
pathogenic bacteria, in which TdfH expression can be activated. Thus, distinct
regulatory profiles of TdfH may contribute to varying levels of virulence between strains.
The data presented in this study resolves conflicting reports of regulation of
TdfG, TdfH and TdfJ in N. gonorrhoeae. We report that TdfG is activated by MisR
specifically in iron depleted conditions identifying for the first time a novel regulator of
TdfG expression that may act independently of Fur. Additionally, we demonstrate for the
first time in N. gonorrhoeae that both TdfH and TdfJ are Zn/Zur repressed implying roles
in Zn acquisition in the gonococcus. Finally, we also report for the first time that TdfH is
differentially regulated between gonococcal strains. We identify MisR to be an activator
of TdfH in strain FA19, but also note that other factors contributing to strain-specific
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TdfH expression may exist. Together these data presents new lines of investigation to
pursue such as the contribution of TdfH and TdfJ to gonococcal Zn acquisition, which
will be discussed in the following chapter.
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Chapter 5: Gonococcal TdT, TdfH, facilitates calprotectin utilization and
contributes to survival in neutrophil extracellular traps

I. Introduction
Transition metals have many functional roles in crucial biological process that
make them a necessary requirement for all living organisms. Zn, in particular, is an
important catalytic and structural component of proteins. As such Zn-binding proteins
are present in all kingdoms of life and represent approximately 8% of eukaryotic and 6%
of archaeal and bacterial proteomes [7]. Zn containing proteins are involved in protein
synthesis and degradation, DNA metabolism and repair, and neurotransmission [8]. The
chemical properties of Zn, that are important for its biological activity also potentiate its
toxicity, thus Zn homeostasis is tightly controlled across all domains of life.
Bacteria require 1nM-10µM Zn for optimal growth [228]. To maintain Zn
homeostasis, bacteria tightly regulate Zn transporters that facilitate Zn uptake and Zn
efflux systems that mediate Zn tolerance. Zn acquisition in prokaryotes primarily occurs
via an ABC transporter, ZnuABC. ZnuABC is comprised of PBP that exhibits high
affinity Zn-binding, an inner membrane permease and an ATP binding domain that
hydrolyzes ATP to provide the energy required to actively transport the substrate into
the cytoplasm. ZnuABC systems are tightly regulated by Zur, a member of the Fur
family of metal response regulators, which can sense sub-femtomolar concentrations of
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cytosolic Zn [23]. In excess Zn conditions, the Zur dimer is associated with Zn and binds
to a specific DNA motif, termed the Zur box, in the promotor of target genes and inhibits
RNA polymerase binding and activity [23]. In low Zn conditions, Zn disassociates from
Zur; apo-Zur has reduced affinity for the Zur box resulting in de-repression of the target
genes. In addition to ZnuABC, low affinity Zn transporters such as ZupT in E. coli, which
is homologous to eukaryotic ZIP family transporters, have also been described [88]. Zn
can also enter bacteria non-specifically through broad specificity metal ion transporters
such as MntH, which is a proton-dependent divalent cation importer and an Nramp
(natural resistance-associated macrophage protein) homologue, as well as MgtA, a Ptype ATPase that may transport Zn as well as Mg. Both MntH and MgtA have been
identified in Salmonella typhimiruim and E. coli [23]. In conditions of excess Zn, Znefflux systems such as ZntA of E. coli facilitate energy dependent efflux of Zn2+ and
Cd2+ from the cytosol to mediate Zn tolerance [23, 86].
Under normal physiological conditions, serum Zn levels are reported to be about
13-20µM and is probably sufficient to support microbial growth [228]. However, the
reduction of serum Zn levels along with the concomitant increase of Zn binding proteins
and Zn uptake in the liver in association with infectious and non-infectious disease has
long been noted [228]. More recently, a variety of mechanisms for host-mediated Zn
limitation have been described. In a mouse model of acute inflammation and infection,
LPS treated mice developed hypozincemia, which was mediated by a cytokine
(primarily IL-6) signaling cascade that stimulates increased synthesis of metallothioein,
a host Zn storage protein, and liver specific Zn importer, ZIP14 [148]. The host strategy
of limiting essential nutrients from invading pathogens has been designated “nutritional
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immunity”. While traditionally characterized as the sequestration of iron from pathogens,
roles for other transition metals such as zinc and manganese are now being examined
[101, 117, 257]. The host protein calprotectin has been identified as a key mediator of
nutritional immunity at sites of infection.
Calprotectin (CP) is a heterodimeric protein complex comprised of S100A8/A9,
members of the calgranulin subgroup of the S100 family proteins, which are low
molecular weight (10-14kDa) and characterized by two EF- hand calcium-binding
domains separated by a hinge region. These proteins are expressed in monocytes, and
can be induced in epithelial cells, endothelial cells, keratinocytes and activated
macrophages [102, 276]. Members of the calgranulin super family including S100A7
and S100A12 in addition to S100A8 and S100A9 have been implicated in inflammatory
diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and
cancer because of their immuno-modulatory roles that lead to overly active immune
responses and pro-tumor environments [78, 102, 182, 276]. S100A8 and S100A9 have
the highest expression in neutrophils where they represent 40-60% of neutrophil
cytosolic proteins. All of the S100 family proteins form homodimers; S100A8 and
S100A9 preferentially form heterodimers. The S100A8/S100A9 heterodimeric complex
is called calprotectin because of its antimicrobial activity attributed to its ability to chelate
transitions metals Zn and Mn [49, 216]. Higher order oligomers, which are responsible
for some biological activities, can also form in a calcium-dependent manner [136].
Calprotectin has two transition metal ion binding sites along the dimer interface.
One site (Site I) binds both Zn and Mn at high affinity, while the other (Site II) only binds
Zn at high affinity [58]. Calcium binding increases the affinity of Zn-binding sites [34].
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Given the calcium ion gradient across the plasma membrane, calcium is thought to act
a molecular switch for Zn-chelating activity whereby cytoplasmic CP primarily exists in a
lower Zn affinity form, extracellular CP is predominately calcium bound and thus adopts
a higher Zn affinity form [34]. CP may also act as an intracellular calcium sensor since
conformational changes that occur as a result of calcium binding during calcium
signaling cascades can modulate calprotectin’s interaction with target proteins [276].
CP can be secreted into the extracellular environment actively via intact
microtubule networks or released by activated neutrophils during neutrophil extracellular
trap (NET) formation or cell necrosis [276]. CP concentrations can reach >500µg/mL at
sites of infection [110]. In vivo, CP accumulates in tissue abscesses upon neutrophil
influx and has been shown to have potent anti-microbial activity against Staphylococcus
aureus [49], Candida albicans [243], Klebesiella pneumonia [1], Acinetobacter
baumannii [100] and Helicobacter pylori [76]. In vitro, the recombinant protein also has
antimicrobial activity against a wide number of pathogens including: Candida albicans
[215], Aspergillus fumigatus [3], P. aeruginosa [57], Staphylococcus epidermis,
Staphylococcus lugdunensis, Enterococcus faecalis, E.coli, and S. flexneri [58], which is
reversed upon zinc supplementation. Given the effective host strategy of Zn limitation,
microbial Zn acquisition systems have been shown to be important for pathogenesis. Zn
uptake systems in C. jejuni, Salmonella enterica, H. ducreyi, uropathogenic E. coli,
Brucella abortus, and Streptococcus pyogenes are required for virulence or colonization
[117].
Pathogenic Neisseria encode the ZnuABC system with homology to the E. coli
ZnuABC system for Zn accumulation [46, 225]. Interestingly, ZnuABC, which has also
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been reported as MntABC, binds both Zn and Mn at equimolar affinities; other bacteria
maintain separate systems with unique binding affinities for each metal [143, 236]. ZupT
was also identified in N. meningitidis as a Fe/Fur repressed gene but is absent in N.
gonorrhoeae [61]. PerR, also known as Zur, is a Fur homolog that represses
Zn/MntABC in the presence of Zn [143, 268]. Microarray analysis of the PerR/Zur
regulon in both N. meningitidis and N. gonorrhoeae revealed that two TonB-dependent
transporters: TdfH and TdfJ were PerR/Zur regulated, suggestive of their roles in Zn
acquisition [181, 268]. In N. meningitidis, the TdfJ homologue, ZnuD, was identified as
the first bacterial outer membrane transporter to facilitate Zn acquisition as it was found
to contribute to meningococcal growth in low Zn conditions [225]. More recently, CbpA,
the TdfH homologue, was found to facilitate meningococcal growth in presence of CP in
a TonB-dependent manner [226]. The functions of the meningococcal homologues of
ZnuD and CbpA have not been tested in N. gonorrhoeae.
In the following studies we examine the role of TonB-dependent transporters,
TdfH and TdfJ in Zn acquisition and CP utilization in N. gonorrhoeae. We also examined
the ability of TdfH and TdfJ to bind CP specifically in the context of whole gonococcal
cells. The studies described herein go further to evaluate the contributions of these
TdTs to Zn accumulation in the presence and absence of CP. Additionally, we
evaluated the contribution of TdfH to gonococcal survival in neutrophil extracellular
traps (NETs). Together with the data reported for N. meningitidis, the results presented
in this study characterize the function of these TdTs in pathogenic Neisseria and report
for the first time the contribution of TdfH to N. gonorrhoeae survival in NETs.
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II. Results
A. TdfH, TdfJ and TonB contribute to growth under Zn restricted
conditions
Given the regulation of these TonB-dependent receptors by Zn/Zur reported in
Chapter 4, we sought to determine whether these receptors contribute to gonococcal Zn
acquisition. We hypothesized that those gonococcal strains lacking a Zn receptor would
be deficient for growth under Zn restricted conditions. Likewise, we expected that upon
supplementation with Zn, growth of wild-type gonococci would recover, whereas strains
lacking receptors contributing to Zn utilization would remain suppressed for growth. To
test this hypothesis, wild type, tdfH, tdfJ, and tonB mutant strains (FA19, MCV927,
MCV928 and MCV650) [227] were grown in GCB treated with Zn-specific chelator,
TPEN in the presence or absence of additional Zn. After growth for 6 hours viable
bacteria were enumerated. As expected, fewer viable wild-type bacteria were recovered
when grown in Zn restricted compared to Zn replete conditions (Figure 17). We found
that significantly fewer viable bacteria were recovered from the tdfH mutant than wild
type after growth in the presence of Zn. Additionally, there was no difference in the
number of bacteria recovered from the tdfH mutant grown with or without Zn, consistent
with a function for TdfH in Zn acquisition. The tdfJ mutant was the most impaired for
growth in Zn replete or depleted conditions; however, growth was partially restored by
addition of Zn. These data suggest that TdfJ is important for growth under Zn restriction
but also imply additional mechanisms of Zn acquisition in the absence of TdfJ
expression. Significantly fewer bacteria were also recovered from the tonB mutant
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Figure 17. Gonococcal growth in Zn replete and Zn restricted conditions.
Wild type (FA19), tdfH (MCV927), tdfJ (MCV928) and tonB (MCV650) gonococcal
strains were grown in GCB treated with Kellogg’s Supplement I, 12μM Fe(NO3)3 and
12.5μM TPEN in the presence or absence of ZnSO4 (18.75μM) for 6 hours before being
serial diluted and spot plated on GCB-VCN plates for CFU determination. Mean and
standard error from a representative of n=3 independent experiments are plotted above.
An un-paired Student’s t-test was used to determine significance. *, P ≤ 0.05; **, P ≤
0.005, n.d., no difference.
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Figure 17. Gonococcal growth in Zn replete and Zn restricted conditions.
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than wild type, indicating that TonB also contributes to growth under Zn restricted
conditions.
B. TdfH is required for growth in the presence of calprotectin
Since both tdfH and tdfJ were found to contribute to growth under Zn restricted
conditions, we tested the possibility that these transporters may be required for the
assimilation of Zn from host derived Zn-binding protein, calprotectin (CP). CP is a
hetero-oligomeric protein complex that constitutes 45% of the cytosolic protein content
of neutrophils [94]. It has been demonstrated to have antimicrobial activity against a
wide range of pathogens, which has been attributed to its Zn 2+ and Mn2+ chelating ability
[49, 216]. We therefore tested the ability of wild type, tdfH and tdfJ mutant strains to
grow in the presence of CP supplemented with Zn under Zn restricted conditions.
Contrary to the antimicrobial activity reported against other pathogens [49, 58], we
found that the growth of wild-type gonococci was enhanced in the presence of Zn –
laden CP (Figure 18). Addition of CP also specifically suppressed growth of the tdfH
mutant, as growth of the tdfJ mutant was similar to that of wild type. These data suggest
that N. gonorrhoeae is capable of overcoming the antimicrobial effects of CP via a
mechanism that requires TdfH. To confirm that TdfH was indeed responsible for the
observed CP resistance, we generated a complemented derivative of the tdfH mutant
strain, MCV956 (tdfHC). Expression of TdfH upon treatment with IPTG was confirmed
(Figure 19). Growth in the presence of CP was restored in tdfHC (Figure 20A),
demonstrating that growth in the presence of CP specifically requires TdfH expression.
Additionally, the tdfH growth defect was specific to CP treatment as neither tdfH nor
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Figure 18. tdfH is defective for growth in the presence of CP
Gonococcal strains were grown under Zn-limited conditions (CDM, 1μM TPEN). Some
cultures were further supplemented with a CP + Zn mixture (10μM CP, 5μM ZnSO 4).
Growth was monitored by OD600 readings every 2 hours for 6 hours. Plotted are the
mean and standard error of the mean of n=2 independent experiments.
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Figure 18. tdfH is defective for growth in the presence of CP
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Figure 19. Expression of TdfH in complimented derivative strain, MCV956 (tdfHC)
Gonococcal strains FA19, MCV927 (tdfH), and MCV956 (tdfHC) were grown in CDM
supplemented with 24μM Fe(NO3)3 +/- 2mM IPTG. Whole cell lysates standardized by
culture density were subjected to SDS-PAGE analysis followed by immunoblotting with
antiserum specific to TdfH.
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Figure 20. Growth in the presence of CP is restored in MCV956 (tdfHC).
Gonococcal strains were grown under Zn-limited conditions (CDM, 1μM TPEN). (A)
Cultures were supplemented with a CP + Zn mixture (10μM CP, 5μM ZnSO4) (B)
Cultures were supplemented 5μM Zn alone or not further treated. Growth was
monitored by OD600 readings every 2 hours for 8 hours. Plotted are the mean and
standard error of the mean of n=3 independent experiments.
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Figure 20. Growth in the presence of CP is restored in MCV956 (tdfHC).
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tdfHC were more defective for growth compared to wild type when supplemented with
Zn alone (Figure 20B).
C. TdfH enables binding of CP by N. gonorrhoeae
Given the ability of N. gonorrhoeae to grow in the presence of CP, we next
sought to determine whether gonococci were capable of CP binding at the cell surface.
Whole gonococcal cells, grown in CDM with Fe(NO3)3 and TPEN, were applied to
nitrocellulose paper, presenting cell surface proteins in their native conformation within
an intact bacterial outer membrane. After blocking, membranes were incubated with Znladen CP, before being washed and probed for CP. CP was specifically detected
associated with wild-type gonococci indicating that N. gonorrhoeae is indeed capable of
binding CP (Figure 21A). Additionally, CP binding was reduced by 80% in both tdfH
isogenic and tdfH tdfJ double mutants in FA1090 indicating that TdfH mediates the
gonococcal/CP interaction. CP binding by wild-type strain FA19 was much reduced
compared to FA1090 consistent with our previous findings that less TdfH was detected
in whole cell lysates of strain FA19 compared to FA1090 (see Figure 15). However, CP
binding was restored in tdfHC upon IPTG induction (Figure 21B) demonstrating that
TdfH specifically facilitates the gonococcal/CP interaction in both FA1090 and FA19.
D. TdfH and TonB are important for Zn accumulation in N. gonorrhoeae
We suspected that TdfH, as a TonB-dependent transporter, and TonB would
contribute to Zn internalization. To test this, we grew wild type, tdfH and tonB mutants
under Zn replete and depleted conditions and assessed the level of internalized Zn
using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). All of the
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Figure 21. CP binding to gonococcal whole cells.
Gonococcal strains were grown in CDM supplemented with 24μM Fe(NO3)3 for 4 hours
before equal culture densities of bacteria were applied to nitrocellulose paper.
Membranes were first blocked before incubation with CP. After washing, blots were then
subjected to immunoblotting using CP specific antiserum. Densitometry was performed
on replicate blots using NIH ImageJ. Signal intensities were normalized to that of wild
type and expressed as % CP binding. A paired Student’s t-test was used to compare %
CP binding; P ≤ 0.05 was considered significant and is designated by an *. (A) A
representative dot blot with gonococcal strains FA1090 (wild type), MCV661 (tdfH),
MCV662 (tdfJ), MCV936 (tdfH tdfJ) applied to nitrocellulose before CP incubation and
detection. Below, densitometry results of n=3 replicate blots are shown. (B) A
representative dot blot with gonococcal strains FA19 (Wild type), MCV927 (tdfH), and
MCV956 (tdfHC) applied to nitrocellulose. TdfH expression in tdfHC was un-induced (UI)
or induced (I) by the addition of IPTG (2mM). Densitometry results of n=3 replicate blots
are shown below the dot blot.
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Figure 21. CP binding to gonococcal whole cells.
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gonococcal strains tested accumulated significantly more Zn when grown under Zn
replete versus Zn-depleted conditions (P-value < 0.05) indicating that the growth
conditions adequately represented Zn replete and depleted conditions (Figure 22).
Additionally, we found that tdfH and tonB mutants internalized significantly less Zn when
grown in both Zn replete and depleted conditions compared to wild type (P-value <
0.05). These data suggest that TdfH and TonB contribute to Zn accumulation.
Given the demonstrated interaction between TdfH and CP and the role of TdfH
and TonB in Zn accumulation (Figure 22A), we determined whether TdfH contributed to
Zn accumulation in the presence of CP. Wild type and tdfH mutants where grown under
Zn depleted conditions in the presence of Zn-laden CP and the levels of internal Zn was
assessed via ICP-OES. We found that the tdfH mutant accumulated less Zn than wild
type in the presence of CP (Figure 22B). These data indicate that TdfH facilitates Zn
assimilation from CP.
E. TdfH contributes to gonococcal NET survival
Gonococcal infection is characterized by a robust recruitment of neutrophils,
which migrate to the site of infection and attempt to eliminate the invading microbes via
phagocytosis and/or NET formation [165]. As a major component of neutrophil cytosolic
proteins, CP is released during NET formation and remains associated with NETs
where it has been demonstrated to be the active component in NET-mediated killing of
Candida albicans [243]. Thus, we sought to determine if gonococcal CP utilization, as
mediated by TdfH, conferred a bacterial survival advantage in the presence of NETs.
Gonococcal opacity proteins (Opa), which are subject to phase and antigenic variation,
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Figure 22. TdfH and TonB contribute to gonococcal Zn accumulation.
Gonococcal strains were grown in Zn replete or depleted media before bacterial cells
were harvested and analyzed for metal levels via ICP-OES. Means and standard error
from a representative of n=3 independent experiments are plotted. An un-paired
Student’s t-test was used to determine significance. *P ≤ 0.05, **P ≤ 0.005. Trends in
statistical significance were consistent between biological replicates. (A) Strains FA19
(WT), MCV927 (tdfH), and MCV650 (tonB) were analyzed for Zn levels. (B) Strains
FA19 and MCV927 (tdfH) were grown in Zn depleted media supplemented with CP + Zn
(2μM CP, 1μM Zn) before bacterial cells were harvested for metal analysis via ICPOES. Means and standard error from a representative of n=3 independent experiments
are plotted.
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Figure 22. TdfH and TonB contribute to gonococcal Zn accumulation.
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have been shown to differentially stimulate and survive exposure to neutrophils [12]. To
eliminate this variability, we constructed a tdfH mutant (MCV955) in the FA1090
Opaless background (Figure 23), and assessed its survival in NETs compared to the
Opaless parent.
Primary human neutrophils were treated with phorbol myristate acetate (PMA) to
activate neutrophils and stimulate NET formation [33]. Activated neutrophils were then
treated with cytochalasin D to inhibit phagocytosis and select for only extracellular
mechanisms of neutrophil killing. DNase I was added to some NETs to assess the role
of intact DNA fibers on NET-mediated killing. Neutrophils were then infected with the
Opaless parent, MCV955 (tdfH) or Δnuc. The Δnuc strain was used as a positive control
for DNase I-reversible sensitivity to NET-mediated killing [115]. We found that while the
Opaless parental strain demonstrated little to no survival defect in the presence of NETs
with or without DNase I, only 40% of the tdfH mutant survived exposure to neutrophils
producing NETs (Figure 24). Additionally, we found that treatment with DNase I
significantly increased survival of the tdfH mutant indicating that intact DNA fibers
contribute to the observed NET sensitivity of the tdfH mutant. These results
demonstrate that TdfH is important for gonococcal resistance to NET-mediated killing.
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Figure 23. Confirmation of tdfH mutant in FA1090 Opaless background.
Gonococcal strains Opaless parent, MCV661 (tdfH) and MCV955 (Opaless tdfH) were
grown in CDM supplemented with 24μM Fe(NO3)3. Whole cell lysates standardized by
culture density were subjected to SDS-PAGE analysis followed by immunoblotting with
antiserum specific to TdfH.
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Figure 23. Confirmation of tdfH mutant in FA1090 Opaless background.
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Figure 24. TdfH enhances bacterial survival in NETs.
Human neutrophils were stimulated to induce NET formation and infected with Opaless,
MCV955 (tdfH) or Δnuc at an MOI= 1 in the presence of Cytochalasin D +/- DNase I for
1 hour. Bacterial survival is expressed as percentage of initial inocula. Mean and
standard error of n=6 independent experiments are shown. Significance was
determined by an un-paired Student’s t-test. *, P-value < 0.05; **, P-value ≤ 0.005.
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III. Discussion
The data presented in these studies demonstrate that N. gonorrhoeae can resist
the host derived Zn-chelating immune effector protein CP. We find that CP resistance is
mediated by the TdT, TdfH, which facilitates CP binding and growth in the presence of
CP. These data demonstrate for the first time that N. gonorrhoeae deploys an additional
strategy to evade nutritional immunity by TdT-dependent utilization of the host nutrient
binding protein, in this case CP. While TdfH was originally suggested to contribute to
heme acquisition due to its similarity to heme receptors, previous studies found that
TdfH was not able to restore heme utilization in an E. coli hemA mutant [238] nor was it
required for gonococcal growth in the presence of heme. The data reported here
demonstrate that gonococcal TdfH is instead a receptor for CP as we have found that it
is required for gonococcal binding of CP and is required for growth in the presence of
CP. These findings are consistent with the report that CbpA, the meningococcal TdfH
homologue, is required for growth of N. meningitidis in the presence of CP and for CP
binding [226]. The current report goes further to demonstrate that TdfH facilitates Zn
accumulation both in the presence and absence of CP in N. gonorrhoeae in support of
the model that TdfH facilitates utilization of Zn from CP to overcome its antimicrobial
effects.
CP has largely been described as having inhibitory activity on the growth of
numerous microbial pathogens [49, 58, 276]. Bacterial Zn acquisition systems in
Aspergillus fumigatus [3], Acinetobacter baumannii [100], Pseudomonas aeruginosa
[57] and Salmonella typhimurium [145] have been reported to facilitate resistance to CP.
Specifically in Gram-negative bacteria, the bacterial factors contributing to CP
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resistance have been limited to the high affinity zinc uptake system, ZnuABC [57, 100,
145]. The report that meningococcal CbpA, binds to CP [226] and our findings that the
gonococcal homologue, TdfH not only binds CP but is also required for Zn accumulation
from CP identifies an outer membrane receptor that can directly interact with CP to
overcome CP mediated Zn sequestration.
At the mucosal epithelia, neutrophils are the first line of defense, localizing to the
site of infection and killing invading microbes by phagocytosis and subsequent
degranulation or via NET formation. Neisseria gonorrhoeae can survive neutrophil influx
through a variety of mechanisms including arresting maturation of phagosomes
containing gonococci, suppressing oxidative burst, and expression of a nuclease in
NETs [55, 112, 115].
NETs are mainly comprised of DNA, histones as well as neutrophil granule and
cytosolic proteins. CP has been detected as major component of NETs [243]. NETmediated killing is thought to occur by ‘trapping’ of microbes by chromatin fibers and
high levels of antimicrobial proteins and molecules like CP and cathepsin G in the
micro-environment of the traps [33]. DNase treatment degrades NETs and destroys the
NET micro-environment and can thus abrogate NET-mediated killing as has been
shown for other bacteria [33]. CP, through its Zn-chelating activity, was found to be the
major antimicrobial component in NETs against Candida albicans, Klebsiella
pneumoniae, and Aspergillus nidulans [1, 17, 243]. DNA was also found to have
antimicrobial activity though metal chelation in NETs [85]. As such, a mechanism to outcompete or overcome host nutrient sequestration strategies would provide a significant
survival advantage. Indeed in N. meningitidis, the Zn-outer membrane transporter,
149

ZnuD was found to contribute to survival within NETs [129]. While we did not evaluate
the contribution of gonococcal ZnuD homologue, TdfJ to NET survival, the data reported
in this study demonstrate for the first time that TdfH facilitates gonococcal resistance to
CP and that TdfH expression contributes to survival in NETs. CP has been shown to be
the key antimicrobial component of NETs; thus, these findings represent a novel
gonococcal neutrophil resistance strategy wherein TdfH assimilates Zn from CP,
neutralizing its antimicrobial activity, to contribute to survival in NETs.
We also report that TdfJ contributes to Zn acquisition in N. gonorrhoeae as fewer
viable bacteria were recovered from the tdfJ mutant compared to wild type when grown
in Zn replete and depleted conditions. The meningococcal TdfJ homologue, ZnuD was
previously reported to have functions in both Zn and heme acquisition [126, 225].
However, our findings, reported in Chapter 3, did not support a role for TdfJ or any other
TdT in gonococcal heme acquisition. ZnuD was also reported to contribute to
adherence, invasion and intracellular survival of N. meningitidis in lung epithelial cells
[126]. Previous studies from our laboratory have found that TdfJ does not contribute to
invasion or intracellular survival of N. gonorrhoeae in cervical epithelial cells [83, 176].
Thus, it appears that while sharing 96% identity with TdfJ, meningococcal ZnuD has
additional functions beyond Zn acquisition that are not observed in N. gonorrhoeae.
Little is known about the Zn concentration at mucosal sites and how Zn is
transported across the outer-membrane of Gram-negative bacteria. It is thought that
transport of the hydrophilic divalent Zn cation occurs passively via porins [86]. Our
findings that TdfH, TdfJ and TonB contribute to Zn acquisition in N. gonorrhoeae as well
as similar findings for the homologous proteins in N. meningitidis [225-226] indicate that
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efficient Zn acquisition in Neisseria is TdT and TonB-mediated. ZnuD homologs with 5060% similarity have also been identified in other Gram-negative pathogenic bacteria
residing primarily in mucosal epithelia [225]. This may indicate that Zn concentrations at
mucosal sites are too low for passive Zn diffusion; as such an outer-membrane Zn
transporter and metabolic energy may be required for active Zn uptake and growth in
those environments [225].
In sum, the data presented in this study indicates that TdfH and TdfJ contribute
to Zn acquisition in N. gonorrhoeae and that TdfH is a calprotectin receptor. These
findings are consistent with functions reported for TdfH and TdfJ homologues in N.
meningitidis [225-226]. The data reported here, goes further to demonstrate that TdfH
also assimilates Zn from CP and that direct utilization of CP enhances gonococcal NET
survival. Our data presents a novel mechanism of gonococcal NET survival and
highlights that many ways in which N. gonorrhoeae have successfully manipulated hostpathogen interactions to its advantage.
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CHAPTER 6: Summary and Perspectives

The host strategy of limiting essential nutrients from invading pathogens, known
as “nutritional immunity” is a prevalent theme in microbial defense. While traditionally
characterized as the sequestration of iron from pathogens [257], roles for other
transition metals such as zinc and manganese are now being examined [101, 117].
TonB-dependent transporters, as key mediators of nutrient acquisition in Gram-negative
bacteria, are at the forefront of this fight for essential nutrients. Neisseria gonorrhoeae is
particularity adept at overcoming host nutritional immunity strategies. Despite being
unable to produce any siderophores to scavenge iron or iron chelates from the ironlimited host environment, N. gonorrhoeae can express eight TonB-dependent
transporters, five of which enable utilization of the following as iron sources:
siderophores produced by other bacteria [36, 98], host iron binding proteins, transferrin
[50] and lactoferrin [20] and the heme binding protein, hemoglobin [43]. Given the role
of the transferrin and lactoferrin receptors in gonococcal pathogenesis [52], it is likely
that the remaining uncharacterized TdTs also have important roles in the ability of N.
gonorrhoeae to cause disease. These transporters also have the potential to be
manipulated for the development of protective and anti-infective therapies. Accordingly,
studies focusing on the function of the uncharacterized gonococcal TdTs, TdfG, TdfH
and TdfJ, are well-justified.
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In this study, we sought to characterize the function and regulation of TdfG, TdfH
and TdfJ in Neisseria gonorrhoeae. To achieve this goal we first sought to determine
the contribution of these receptors to gonococcal heme utilization. TonB-independent
heme utilization has been demonstrated in N. gonorrhoeae [19]; although it is not
expected to be biologically relevant in vivo, where low heme levels would necessitate
receptors that enable active and efficient heme utilization [19, 133, 209]. Given their
similarity to heme receptors, TdfG, TdfH and TdfJ were naturally considered as
candidates for gonococcal heme TdTs. However, neither TdfG nor TdfH were found to
contribute to heme utilization in N. gonorrhoeae [238]. ZnuD, the meningococcal TdfJ
homolog, binds heme and restores heme utilization in an E. coli hemA mutant but it is
not required for heme utilization in N. meningitidis [126] indicating that alternative
mechanisms of heme utilization outside of ZnuD may exist.
In order to reconcile these reports we addressed the possibility that these
receptors may be functionally redundant and generated double mutants incapable of
expressing either TdfG and TdfJ or TdfH and TdfJ. When growth of these strains was
evaluated, neither the TdTs nor TonB was found to contribute to growth. Additionally,
TonB was not required for growth in a gonococcal heme auxotroph, dependent on
exogenous heme uptake. Together these results indicate that TonB and by definition
TdTs are not required for heme uptake in N. gonorrhoeae. Contrary to previous
suppositions, we find that gonococcal heme utilization occurs independently of TonB
and is thus passive even at low heme concentrations. These findings are in stark
contrast to reports in other bacteria, which indicate that free heme utilization requires
high affinity heme receptors for active TonB-dependent transport of heme [133]. It is not
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clear why heme utilization in N. gonorrhoeae is TdT and TonB-independent. We
postulate that the increased permeability of N. gonorrhoeae outer membranes to
hydrophobic agents compared to other Gram-negative bacteria may allow for passive
non-specific heme entry.
We also addressed the possibility that the TdTs may not be required for free
heme uptake but may facilitate utilization of a bacteria derived hemophore as a heme
source analogous to N. gonorrhoeae xenosiderophore utilization [36, 98]. We identified
a candidate hemophore and tested its ability to support gonococcal growth as a sole
iron and/or heme source. We found that P. gingivalis hemophore-like protein, HusA,
could not support gonococcal growth. While our results appear to suggest that N.
gonorrhoeae does not encode a “xeno-hemophore” utilization system, further studies
with different types of hemophores will be needed to confirm that conclusion since the
bacterial hemophores described thus far are structurally and functionally diverse [253].
In the next objective of this study, the regulation of these TdTs was evaluated. All
TdTs that facilitate the utilization of iron or iron-chelates are iron repressed. These TdTs
are differentially regulated by iron; TdfG is iron-repressed, TdfH is not iron responsive
and TdfJ is iron-induced, suggesting that some of these receptors may have functions
outside of iron uptake. To better understand the context in which these receptors may
be expressed and ascertain some information about their function, we assessed their
expression in the absence of Fur, MisR and MpeR, which are all regulators of Neisseria
virulence factors. We found that both Fur and MisR contribute to the iron regulation of
TdfG. While Fur repressed TdfG expression in iron replete conditions, MisR activated
TdfG expression in iron depleted conditions. Given the specificity of TdfG to Neisseria
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gonorrhoeae and its regulation by MisR, which may be important for Neisseria
adaptation to host cells [107], we predict that TdfG contributes to gonococcal
pathogenesis by facilitating iron acquisition from a host specific source. TdfG is the
largest gonococcal TdT; its larger size may indicate that it binds a protein ligand as
opposed to a siderophore [226].
We also found that TdfH and TdfJ are Zn-repressed and Zur regulated and that
TdfH expression is distinct in different gonococcal strains. In N. gonorrhoeae strain
FA1090, TdfH is not MisR regulated. However, overall levels of TdfH detected are
reduced in strain FA19 compared to FA1090 and TdfH is MisR activated. TdfH
expression is almost always detected in Neisseria meningitidis and Neisseria
gonorrhoeae strains but is rarely detected in commensal Neisseria species despite the
presence of tdfH in most Neisseria genomes [155, 226, 238] suggesting that TdfH
expression is differentially regulated in pathogenic versus commensal Neisseria. Our
studies did not find TdfH to be regulated by pathogenic Neisseria specific regulator
MpeR in gonococcal strain FA1090, but this may be not be the case in different
gonococcal strains. As such further studies to determine the direct or indirect
contribution of any potential regulators should be conducted in multiple strains.
Our findings emphasize the importance of characterizing gene products in
various strains given the evidence of strain specific differences. FA19 and FA1090 are
both routinely used lab strains but have reported genetic and phenotypic differences. In
FA19, expression of the mtrCDE encoded efflux pump is inducible but is not in FA1090
due to a deletion in MtrA, an AraC-like activator of the efflux pump [200]. Also, FA19
encodes the gonococcal genetic island (GGI) while FA1090 does not. Components of a
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GGI encoded Type IV secretion system confer a TonB and TdfF-independent
mechanism of intracellular survival in FA19 [279]. Additionally, xenosiderophore
utilization in FA19 is TonB and TdT-independent but is FetA dependent in FA1090 [98,
227]. FA19 was originally isolated from a patient with uncomplicated infection and
FA1090 isolated from the cervix from a patient with disseminated infection.
Characterizing regulatory differences between strains will help to better understanding
the variety of potential expression patterns of gene products during natural gonorrhea
infections.
In the final objective of this study, the contribution of TdfJ and TdfH to
gonococcal Zn utilization was evaluated given their observed Zn/Zur repression. We
found that TdfH, TdfJ and TonB were all important for growth in Zn depleted conditions
indicating that Zn-utilization is TonB and TdT-dependent in N. gonorrhoeae. Zn passage
across the outer-membrane of Gram-negative bacteria is thought to occur passively,
potentially through porins [86]. The identification of two TdTs that facilitate Zn
acquisition and are expressed in naturally occurring isolates of N. gonorrhoeae and N.
meningitidis [225-226, 238] indicate that Neisseria must encounter low Zn
concentrations in vivo and that efficient Zn utilization may in some conditions require
TdTs. ZnuD homologs have been identified in pathogenic bacteria of the respiratory
tract including Moraxella catarrhalis, Acinetobacter baumannii, and Bordetella pertussis
[225] suggesting that active, TdT-mediated Zn acquisition may be a wide-spread theme
in mucosal pathogens. Studies investigating the function of these homologs and their
contribution to pathogenesis will be needed to better understand the importance of TdTmediated Zn acquisition.
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This study also reports that TdfH is a calprotectin receptor. We demonstrate that
TdfH is required for growth in the presence of CP, specifically binds CP and
accumulates Zn from CP. These findings along with those reported for CbpA, the
meningococcal TdfH homolog [226] identify a novel host protein that pathogenic
Neisseria hijack to acquire the essential nutrient Zn.
Many studies have focused on the antimicrobial effects of CP in vitro and in vivo
[49, 58]. Several studies have found that Zn transport systems, specifically ABC
transporters in Gram-negative bacteria enhance survival in the presence of CP [3, 57,
100, 145]. This study along with that reported in N. meningitidis, represent the first
reports of a surface receptor that binds to CP and is critical for CP resistance [226].
TdfH homologs are present in other bacteria, thus CP receptors may represent a new
theme in microbial resistance to nutritional immunity. Apart from Neisseria spp. where
TdfH homologs share over 90% identity, we have detected TdfH homologs in mostly
opportunistic pathogens that normally colonize the human respiratory tract or mouth
(Table 8). These homologs show 50-60% identity to TdfH and are often annotated as
heme utilization proteins. One of such proteins, Hup of H. influenzae, shares 52%
identity with TdfH and has been shown to contribute to heme utilization [166, 238],
though our findings reported in Chapter 3 as well as previous reports [238] indicate that
TdfH does not contribute to heme utilization in N. gonorrhoeae. As such, studies
investigating the function of homologous TdTs will be needed to determine whether they
are actually heme or CP receptors. Additional studies identifying epitopes involved in
CP binding and Zn coordination will also help to better annotate homologs and further
characterize this novel class of TdTs.
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Calprotectin is highly expressed in neutrophils and is an active antimicrobial
component of NETs [243]. Thus, we also evaluated the contribution of TdfH to N.
gonorrhoeae NET survival and found that TdfH enhances gonococcal NET survival.
Neutrophil recruitment is a hallmark of gonococcal infection. Despite the role of
neutrophils in innate immunity, the ability to recover viable N. gonorrhoeae from
neutrophil rich urethral exudates indicate that neutrophils are ineffective at clearing
gonococcal infection [56]. Neisseria gonorrhoeae have a plethora of mechanisms to
resist neutrophil mediated killing including resistance to oxidative stress, modulation of
neutrophil granule release and efflux of antimicrobial components [56]. N. gonorrhoeae
also induce NET formation independently of Opas and Pili, though these virulence
factors can modulate NET formation [82].
Surprisingly, N. gonorrhoeae induced NETs do not stimulate ROS nor do they kill
the bacteria [82] indicating that N. gonorrhoeae has NET resistance strategies. Recently
N. gonorrhoeae was found to secrete a nuclease that facilitates escape from NETs
[115]. Our findings that TdfH enhances gonococcal NET survival define a novel strategy
of gonococcal NET resistance: direct utilization of CP as a Zn source, which neutralizes
CP antimicrobial activity. In N. meningitidis, ZnuD was also found to be important for
NET survival [129]. We did not evaluate the contribution of gonococcal ZnuD homolog,
TdfJ to NET survival, though we suspect that it may also contribute to NET survival
given its potential to mediate Zn acquisition. The evidence that TdTs involved in Zn
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Table 8. TdfH homologs in opportunistic pathogens
Organism

Family

Disease

Accession
number

%
Identity

Acintobacillus ureae

Pasteurellaceae Pneumonia, chronic
respiratory disease

WP_005621380.1

52

Aggregatibacter
actinomycetemcomitans

Pasteurellaceae Periodontis, bacterial
endocarditis

WP_005578440

60

Haemophilus
haemolyticus

Pasteurellaceae Bacteremia, pneumonia,
endocarditis

WP_005630735.1

51

Haemophilus influenzae

Pasteurellaceae Bacteremia, pneumonia,
otitis media, epiglottitis,
meningitis

AAS75800.1

51

Moraxella catarrhalis

Moraxellaceae

Sinusitis, otitis media,
bronchitis, pneumonia

WP_013107855.1

54

Morococcus cerebrosus

Neisseriaceae

†Cerebellar

WP_039407935.1

65

†Only

abscess,
Endopthalmitis,

two instances of disease by M. cerebrosus have been reported; see refs. [149,

235]
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acquisition contribute to NET survival indicate that nutritional immunity via CP-mediated
Zn sequestration is a major component of NET-mediated killing.
In all, the data presented in this study has yielded new information into the
function and regulation of these TdTs in N. gonorrhoeae. Our initial characterization of
TdfH as a CP receptor has laid the foundation for the description of a new class of TdTs
that utilize CP as a nutrient source conferring a novel neutrophil/ NET resistance
strategy. Understanding gonococcal mechanisms that subvert neutrophil defenses will
help to expose pathways that can be manipulated for successful clearance of
gonococcal infection. Furthermore, these TdTs may be good targets for novel and
specific anti-gonorrhea therapies since they are surface-exposed, widely conserved in
Neisseria gonorrhoeae strains and are not phase variable. Additionally, this study has
revealed new insights into the conditions in which these TdTs may be expressed and
strain specific differences in their regulation. These findings have opened new lines of
investigation to further ascertain the functional mechanisms governing these TdTs as
well as their potential for use as targets of protective and therapeutic strategies against
gonococcal infection.
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